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Within pharmaceutical analysis, sample preparation is essential to make a sample compatible 
with the chosen analytical instrument, prevent contamination and damage of the instrument, 
and to avoid interference from matrix substances in biological samples. Electromembrane 
extraction (EME) was developed in the mid-2000s, and has proved to be an efficient sample 
preparation technique for several analytes. It is based on transfer of electrically charged 
analytes from an aqueous donor solution, across an organic solvent (SLM), and into an 
aqueous acceptor solution. There are several advantages with EME, including the possibility 
of rapid extractions, high sample clean-up and enrichment, high selectivity, low consumption 
of organic solvents, and pre-concentration of the analyte.  
 
To this date, most studies on EME have been performed with non-polar, basic analytes. In the 
present study, EME was for the first time used for sample preparation of methotrexate (MTX) 
and its metabolites 7-hydroxymethotrexate (7-OH-MTX) and 2,4-diamino-N10-methylpteroic 
acid (DAMPA). These are polar, acidic, and zwitterionic analytes, all physicochemical 
properties that are little explored with EME.    
 
For MTX method development, a range of different conditions were tested and optimized in 
order to yield high analyte recoveries. The extracted samples were analyzed using HPLC-UV 
during method development. MTX was extracted as either positively or negatively charged, 
with subsequent adjustments of pH in the donor/acceptor solutions and composition of the 
SLM. Due to the polarity of the analyte, an ionic carrier was added to the SLM. The highest 
recovery (79.6%) was achieved when MTX was extracted as an anion, using a 40 mM 
phosphate buffer with pH 7.4 as the donor solution, 10 mM NaOH with pH 12 as the acceptor 
solution, and peppermint oil + 1% aliquat 336 as the SLM. The same method yielded 
recoveries of 59.0% 7-OH-MTX and 32.4% DAMPA in the acceptor solution.  
 
This method could not be applied to a donor solution containing a physiological concentration 
of Cl-, due to an interaction between the chloride ions and the cationic carrier aliquat 336. 
Therefore, MTX was extracted as a positively charged analyte from plasma, using an anionic 
carrier for transport across the SLM. The extracted plasma samples were analyzed using LC-




Taken together, MTX should be extracted as an anion to achieve high recovery, and the 
addition of an ionic carrier is essential for transport across the SLM. Of all the conditions 
tested, results pointed towards the most optimal donor/acceptor solutions, SLM, ionic carrier, 
and settings for voltage, time, and agitation. However, further experimental work is required 
in order to improve EME of biological samples, particularly to identify an ionic carrier which 
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BEA   Bis-(2 ethylhexyl)amine 
DAD  Diode array detection 
DAMPA  2,4-diamino-N10-methylpteroic acid 
DC   Direct current 
DEHP  bis(2-ethylhexyl) phosphate 
DHFR  Dihydrofolate reductase 
dTMP  Thymidine monophosphate 
EME  Electromembrane Extraction 
FH4  Tetrahydrofolate 
G6PDH Glucose-6-phosphate dehydrogenase 
GC   Gas chromatography 
HF-LPME  Hollow fibre Liquid phase microextraction 
HPLC   High performance liquid chromatography 
IS   Internal standard 
LC   Liquid chromatography 
LC-MS  Liquid chromatography-mass spectrometry 
LLE  Liquid-Liquid extraction 
LPME  Liquid phase microextraction  
MEC   Minimum effective concentration   
MRM   Multiple reaction monitoring 
MS   Mass spectrometry 
MS/MS Tandem mass spectrometry (triple quadrupole mass spectrometruy) 
MTC   Minimum toxic concentration 
MTX   Methotrexate 
NPOE  2-nitrophenyl octyl ether 
NPPE   2-Nitrophenyl pentyl ether 
PBS   Phosphate buffered saline 
PP   Polypropylene 
RF   Radio frequency 
RCF   Relative centrifugal force  
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RPM   Revolutions per minute 
RSD   Relative standard deviation 
SDME  Single-drop microextraction 
SLM   Supported liquid membrane 
SPE   Solid Phase extraction 
TDM   Therapeutic drug monitoring 










1 Introduction  
 
  1.1 Methotrexate 
 
Methotrexate (MTX) was developed as an anticancer agent in 1940 (1). Today, it is used to 
treat a range of different diseases (2). In low doses, it is effective against several autoimmune 
diseases, such as rheumatoid arthritis and psoriatic arthritis. In high doses (> 500 mg/m2), it is 
applied to treat cancers like adult and childhood acute lymphoblastic leukemia, malignant 
lymphoma, and osteosarcoma. MTX is an antimetabolite, which means that it works by 
inhibiting processes involved in synthesis of DNA or its nucleotide building blocks (3). MTX 
inhibits dihydrofolate reductase (DHFR), an enzyme important to maintain adequate amounts 
of the enzyme cofactor FH4 (tetrahydrofolate). In cells deprived for FH4, the synthesis of the 
DNA building block thymidine monophosphate (dTMP) would stop, leading to slower DNA 
synthesis and cell division. DHFR reduces folic acid into FH2, and further reduces FH2 into 
FH4. MTX inhibits both processes. 
 
Figure 1. Mechanism of action of MTX. Adapted from (3). 
 
Most of the administered dose of MTX (60-90%) is eliminated unchanged in the urine (2). In 
the liver, MTX can be converted into the metabolite 7-hydroxymethotrexate (7-OH-MTX). 
This compound is less soluble than MTX and may contribute to nephrotoxicity, which will be 
covered in the next paragraph. To a lesser extent, MTX is metabolized in the intestine to the 
non-toxic 2,4-diamino-N10-methypteroic acid (DAMPA). 
 
High dose MTX may cause significant toxicity to some patients (4). Acute kidney injury is a 
serious condition that may arise due to precipitation of MTX and 7-OH-MTX in the renal 
tubules. As a result, reduced clearance and resultant accumulation of toxic concentrations of 
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MTX and 7-OH-MTX may occur. This can further worsen the injury to the kidneys and 
increase the risk of additional adverse side effects, such as myelosuppression, mucositis, and 
hepatotoxicity. The incidence of acute kidney injury depends on preventive measures, the 
dose and schedule of MTX, and individual pharmacokinetic variations among patients. Both 
MTX and 7-OH-MTX are acidic and poorly soluble at acidic pH. Alkalization of the urine 
will therefore greatly increase the solubility and elimination of MTX and 7-OH-MTX, and it 
is recommended to administrate fluids containing sodium bicarbonate during and after 
administration of high dose MTX. Many patients experience reduced intravascular fluids due 
to vomiting and diarrhea, leading to reduced urine production. Hydration is therefore an 
important strategy to prevent concentrated urine and nephrotoxicity. Folinic acid is a derivate 
of folic acid, administered to protect normal cells from toxicity. It competes with MTX over 
the binding site on DHFR, allowing the formation of FH4. Since folinic acid neutralizes the 
effect of MTX, the two agents must not be taken simultaneously, since this will reduce the 
anticancer effect of MTX.  
 
  1.2 Therapeutic drug monitoring of MTX 
 
Although the dose of MTX needs to be kept low enough to avoid toxicity, it must be 
sufficiently high to provide the desired anti-cancer effect (2). MTX has a narrow therapeutic 
window, which means that the range between minimal effective concentration (MEC) and 
minimal toxic concentration (MTC) is small. It is therefore necessary to keep the serum 
concentration within this range. Although MTX is administered in a fixed dose and duration, 
individual differences between patients can contribute to varying serum concentration of 
MTX. These differences, or host factors, may be age, gender, renal and hepatic function, and 
comorbidities. A patient may also be using other medications that can interact with MTX and 
contribute to delayed elimination. To ensure that the dose of MTX is below the MTC, but still 
high enough to overcome the MEC, therapeutic drug monitoring (TDM) is performed. 
 
TDM aims to ensure the optimal dosage of a drug to each patient, by analyzing the serum- or 
plasma drug concentration and comparing it to a target range (5). Most drugs have a relatively 
large therapeutic window, which means that the range between MEC and MTC is broad. The 
risk of toxicity is therefore small, and TDM is not a required practice. TDM is neither 
necessary when the therapeutic effect can be measured by other means. For example, the 
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blood pressure of a patient gives a clear indication to whether an antihypertensive drug is 
dosed correctly. Some of the main cases where TDM is performed are listed below (5): 
1. When there is an experimentally determined relationship between the plasma drug 
concentration and the pharmacological effect. TDM is beneficial when individual 
pharmacokinetic and pharmacodynamic variations between patients can lead to 
differences in dose-response relationship.  
2. To avoid toxicity and lack of effectiveness for drugs with a narrow therapeutic 
window. Both lack of effect and toxicity may put a patient at risk, and TDM can 
help prevent this outcome. 
3. For patients with problems related to drug compliance. TDM can be performed to 
examine whether a patient has taken the prescribed dose of drug by analyzing 
serum values.   
As already mentioned, the first two points address the importance of monitoring high dose 
MTX. However, these aspects, including the third point, are also relevant to patients treated 
with low dose MTX. Approximately 40% of rheumatoid arthritis patients show no clinical 
improvement in response to MTX (6). Reasons for this can be individual variations in MTX 
absorption and metabolism, non-compliance, or prescription of insufficient MTX dose. 
Increases in dosage due to lack of effectiveness must be performed with caution, because it 
may in turn lead to increased toxicity. TDM is therefore an option to identify which patients 
will respond well to the drug, so that the correct drug can be established early. If a patient is 
non-compliant or experiences no effect from the drug because of low serum levels, TDM can 
prevent switching from MTX to other, more expensive medications on the incorrect 
assumption that lack of therapeutic response is due to poor efficacy rather than insufficiently 
high drug plasma levels. 
 
  1.3 TDM in patients receiving high dose MTX 
 
TDM of MTX is a common practice in many hospitals in Norway (7). Haukeland University 
Hospital performs routine TDM in patients receiving high dose MTX. The time after 
administration and number of measurements differ according to dose, duration of infusion and 
the clinical status of the patient. Serum samples are analyzed by a homogeneous enzyme 
immunoassay method called ARK Methotrexate Assay (8). In principle, two reagents are 
added to the serum sample. One contains methotrexate labeled to the enzyme glucose-6-
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phosphate dehydrogenase (G6PDH), and the other contains rabbit polyclonal antibodies to 
methotrexate. MTX from the serum sample will compete with MTX labeled to G6PDH for 
binding to the antibodies. If the latter binds, enzyme activity decreases. If the serum MTX 
binds, the enzyme activity increases, and the activity is directly proportional to the drug 
concentration. The active enzyme will convert the coenzyme NAD to NADH, which is 
measured by photometry.   
 
Figure 2. Principle of the ARK Methotrexate assay. 
 
The immunoassay method is effective for routine TDM (8). It is fast and does not require 
sample preparation. The measurement range is 0.04-1.20 µmol/L, and higher concentrations 
must be diluted prior to analysis. The method shows linearity and high recovery (mean 
percentage recovery = 104.2%) within the measurement range. Despite the advantages of the 
ARK Methotrexate Assay, it has one specific limitation that will be discussed in the next 
section. 
 
Glucarpidase is an antidote administered to patients with delayed MTX clearance due to 
impaired renal function (9). For example, for a dose of 8-12 g/m2 MTX infused over 6 hours 
or less, and the 42-hour concentration is above 10 µM, glucarpidase may be indicated. The 
antidote works by cleaving extracellular MTX into the non-toxic metabolites DAMPA and 
glutamate (4). The ARK Methotrexate Assay is not able to distinguish MTX from the 
DAMPA metabolite within 48 hours after glucarpidase administration. This is due to a cross 
reaction between DAMPA and MTX, leading to a false elevated estimation of the MTX 
concentration. With the current technology, only a chromatographic method, like high 
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performance liquid chromatography (HPLC), can separate the two compounds and estimate 
the true MTX concentration.  
 
At present, samples from patients treated with glucarpidase are sent from Haukeland 
University Hospital to Rikshospitalet in Oslo for analysis. In a conversation with Anders M. 
Andersen from Oslo University Hospital (February 2021), it was explained that they receive 
up to 5 samples yearly, but the number varies. Since 1990, a high-performance liquid 
chromatography-ultraviolet detection (HPLC-UV) method has been applied for analysis of 
MTX and DAMPA, but a liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
method is now fully developed and pre-validated. Mass spectrometry (MS) is a highly 
valuable detector because of its high selectivity, and ability to detect very low concentrations 
of analytes (10). The theory behind HPLC-UV and LC-MS/MS will be covered in section 2.2-
2.4. Hence, MTX is separated from the DAMPA metabolite prior to detection, resulting in a 
more reliable measurement of MTX concentration.  
 
  1.4 TDM in patients receiving low dose MTX 
 
In addition to sample analysis from patients treated with glucarpidase, the new LC-MS/MS 
method in Oslo will be applied to routine TDM for patients that receive low dose MTX. The 
measurement range of this method is 0.1 to 24 nmol/L. The therapeutic range is not defined 
yet, and will depend on the dose, and the time between administered dose and analysis, 
according to an e-mail from Anders M. Andersen in February 2021. In Haukeland University 
Hospital, routine TDM is not performed on patients who receive low dose MTX because the 
serum concentration levels are below the detectable limit of the immunoassay method (11).  
 
Regardless of whether HPLC-UV or LC-MS/MS is the chosen analytical technique used for 
TDM of MTX, sample preparation is required. According to the e-mail from Andersen, 
Rikshospitalet in Oslo applies protein precipitation (PP) as their standard sample preparation 
method prior to HPLC-UV, achieving approximately 70% recovery of the analyte. For the 
new LC-MS/MS method, PP will also be used, but the degree of recovery is not yet 
established. The importance of sample preparation, and differences between PP and other 




  1.5 Sample preparation 
 
Bioanalysis involves the identification and quantification of a compound (e.g., drug 
substance) in a biological sample, such as human blood, saliva or urine (12). As well as being 
performed in hospitals for TDM, bioanalysis can be applied to different areas. It is significant 
in drug development and clinical testing in pharmaceutical industry. In forensic and doping 
laboratories, bioanalysis can reveal recreational drug abuse, or drug abuse in sports. The 
process of bioanalysis can be divided into three steps: sample preparation, analyte separation, 
and detection (13).  
 
Sample preparation is the first step in bioanalysis, and it is applied because most biological 
fluids are too complex to be injected directly into an analytical instrument. There are several 
reasons for this, and some of them are mentioned below (14):  
1. Biological fluids can contain matrix substances that suppress, or falsely elevate the 
target analyte signal. 
2. Biological fluids can contain matrix substances that contaminate the analytical 
instrument. 
3. The biological fluid is incompatible with the analytical instrument because it is 
aqueous.  
4. The concentration of target analyte is too low to be detected by the instrument. 
 
The international Union of Pure and Applied Chemistry (IUPAC) compendium of Chemical 
Terminology (“Gold book”) defines matrix effects as “The combined effect of all components 
of the sample other than the analyte on the measurement of the quantity. If a specific 
component can be identified as causing an effect then this is referred to as interference” (15). 
The cross reaction between DAMPA and MTX in the ARK Methotrexate Assay, where the 
signal for MTX is falsely elevated due to presence of DAMPA, is an example of interference 
that may have clinical significance. A way to approach this problem without sending the 
samples to Oslo for chromatographic analysis would be to apply a sample preparation method 
which removed DAMPA from the sample prior to analysis. However, there is currently no 
such technique in use. Nevertheless, it would be of interest to measure both MTX and 





Matrix effects can also cause drawbacks in LC-MS instruments, where ion suppression is a 
common problem (16). The mechanism is not fully understood, but it is believed that 
endogenous compounds (salts, carbohydrates, amines, urea, lipids, peptides, or other organic 
molecules) enter the mass spectrometer (MS) at the same time as the target analyte. These 
compounds may increase the viscosity and surface tension of the droplets produced by 
electrospray ionization (ESI), which will reduce the ability of the target analyte to enter the 
gas phase. In turn, this will impair its detection.  
 
Another problem related to the complexity of biological fluids, is that the sample may contain 
components that can damage the instrument or reduce its performance over time (17). For 
example, serum or plasma samples can usually not be injected directly into a liquid 
chromatography (LC) system, because the samples contain proteins that can contaminate and 
clog the columns. LC-MS instruments are susceptible for contamination, for example by non-
volatile compounds accumulating in the ion source (18). This requires more frequent 
instrument maintenance to avoid signal suppression.  
 
The sample must be compatible with the instrument of choice (14). All biological fluids are 
aqueous, and aqueous solutions are readily compatible with an LC-system. If a target analyte 
is better suited for gas chromatography (GC) analysis, it should be transferred to an organic 
solvent prior to injection into the system. This is because the sample must evaporate in order 
to be separated and detected by GS (19). Typical analytes analyzed by GC are volatile, small, 
and nonpolar compounds. Most pharmaceuticals are either relatively polar or too large to be 
evaporated by GC, and LC is therefore more frequently applied in bioanalysis than GC.  
 
The target analyte in biological samples may be present in concentrations that are too low for 
the instrument to detect (20). To achieve higher concentrations, a sample preparation method 
can be applied, where the target analyte is extracted from a sample solution into a smaller 
volume acceptor solution. This causes pre-concentration of the target analyte and will enhance 
the detection signal. However, today’s LC-MS instruments are highly sensitive and can detect 
very low concentrations, and pre-concentration has therefore become a less important step in 




  1.6 Sample preparation methods 
 
Sample preparation is often the most time consuming and laborious step of bioanalysis, which 
emphasizes the importance of choosing an optimal protocol (1). The most common sample 
preparation techniques used prior to LC-MS analysis are protein precipitation (PP), solid 
phase extraction (SPE) and liquid-liquid extraction (LLE) (12). These methods are 
continuously optimized and validated to improve the quality of the LC-MS analyses.  
 
Protein precipitation is useful to remove proteins in a sample prior to separation in LC (21). A 
precipitant, typically methanol, acetonitrile, or trichloroacetic acid, is added to the sample, 
and the mixture is shaken, leading to precipitation of proteins. The mixture is further 
centrifuged, and the supernatant is collected for analysis. PP is a rapid procedure, requires 
minimal equipment, can be automatized, and the method development is relatively simple 
(14). However, it provides limited sample clean-up. A complex mixture of endogenous 
compounds will remain. One example is phospholipids, which are particularly known to cause 
ion suppression in LC-MS, affecting the reliability of quantitative measurements. In addition, 




Figure 3. Principle of protein precipitation. Adapted from (14).  
 
Alternatively, a drug can be isolated from a sample by extraction, which gives a purer extract 
(14). In solid-phase extraction (SPE), an extraction column is packed with a stationary phase. 
When the sample is applied to the column, some analytes interact with the stationary phase 
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and are retained. A washing step is then applied, where additional matrix substances elute, 
while the analytes of interest still interact with the stationary phase. Lastly, a suitable liquid is 
applied to the column to break the interactions between the analyte and stationary phase, and 
the final solution is collected for further analyses. This extract contains the analyte and is free 
of major matrix substances.  
 
Liquid-liquid extraction (LLE) is based on the transfer of a target analyte from the aqueous 
biological sample into an organic solvent (14). The organic solvent is immiscible with water 
and will form a two-phase system with the aqueous biological sample. The samples are 
vigorously mixed, and the exchange of analytes occur in the interface between the organic and 
aqueous phase, see Figure 4. The distribution of analytes between the two liquid phases 
depends on their partition ratios. To obtain high partition ratios towards the organic phase, the 
organic solvent must be carefully selected for the particular analyte, facilitating molecular 
interactions between the analyte and the organic solvent. In general, compounds with low 
polarity are best suited for LLE. Since many substances of interest are either acidic or basic, 
the pH value of the biological sample needs to be adjusted to maintain the analyte in a neutral 
state. This is because ionized analytes are more soluble in water than in an organic solvent. 
Acidic substances should therefore be extracted from a sample with a pH value at least two 
units from the pKa-value of the analyte.  
 
 





  1.7 Development of Electromembrane extraction  
 
Research on microextraction techniques is a very active field (12). Compared to traditional 
LLE, liquid phase microextraction (LPME) provides several advantages. The consumption of 
organic solvent is considerably reduced, leading to a “green chemistry” approach. Effective 
pre-concentration is possible, due to transfer of analytes into a few microliters of liquid. 
Different LPME-systems aim to simplify the extraction approach, increase efficiency, 
selectivity, and sample cleanup (20). Also, the potential of automation is an area of interest. 
Automation of microextraction techniques will make the analyses more accurate and 
repeatable, as well as increasing the overall efficiency.  
 
The first LPME technique was single-drop microextraction (SDME), introduced in 1996 (12). 
In SDME, the organic solvent phase consists of a few microliters and is located at the tip of a 
micro-syringe needle. Normally, the droplet is lowered into the sample solution. The two 
phases are immiscible, but stirring the sample will promote mass transfer of the analyte from 
the sample solution into the droplet. The operation is very simple, but a major drawback is 
that the droplet can be lost to the sample. 
 
Over more than two decades, other LPME alternatives have evolved, including hollow fiber 
LPME (HF-LPME) (13). In HF-LPME, the analytes are extracted from the sample solution 
through an organic solvent, and further into a few microliters of acceptor solution (Figure 5). 
The organic solvent, named supported liquid membrane (SLM), is immobilized by capillary 
forces in the pores in the wall of a hollow fiber membrane. It comprises only a few microliters 
of organic solvent and is immiscible with water. The acceptor solution is located inside the 
lumen of the hollow fiber membrane (12). It can be either organic (two phase system) or 
aqueous (three phase system). The aqueous acceptor phase is compatible with LC. This is a 
notable advantage compared to traditional LLE, where the acceptor phase is an organic 
solvent and must be reconstituted in another liquid before injection into LC (14). A three-
phase system also noticeably enhances method selectivity because the sample solution and 






Figure 5. Principle of HF-LPME. Downloaded from (12). 
 
In HF-LPME, the driving force for mass transfer through the supported liquid membrane is 
passive diffusion, achieved by a strong pH-gradient (22). For basic analytes, donor solution 
must be basic, and the acceptor solution must be acidic. The substance will diffuse into the 
SLM based on its donor solution-membrane distribution constant, and be further extracted 
into the acceptor solution. The acidic acceptor solution facilitates ionization of the substance 
once it reaches the acceptor side of the SLM (23). Since ionized substances are more soluble 
in aqueous solutions, the substance will be trapped in the acceptor phase. 
 
Electromembrane extraction (EME) was developed in 2006 (13). Like HF-LPME, analytes 
are extracted from a donor solution across the SLM, into an acceptor solution. However, 
instead of mass transfer being based on diffusion, an electrical field facilitates electrokinetic 
migration of the analytes. Electrodes are placed in the donor and acceptor solution, coupled to 
an external power supply. When extracting acidic analytes, the negatively charged electrode 
(cathode) is located in the donor solution and the positively charged electrode (anode) in the 
acceptor solution. The pH in the donor and acceptor solutions is adjusted to a level where the 
analytes are ionized (24). For acidic analytes, this means that the pH must be above their pKa-
value to assure de-protonation of the molecules. This will cause electrokinetic migration 
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towards the electrode with opposite charge. For basic substances, the electrical field and pH 
requirements are reversed. The theory of EME will be covered in detail in section 2.1.  
 
There are several advantages with EME (25). If the volume of the acceptor solution is smaller 
than the donor volume, this will cause pre-concentration of the analytes. EME has the 
potential to provide high selectivity and sample clean-up. The SLM prevents polar matrix 
components from entering the acceptor solution, and the electrical field prevents matrix 
components of opposite charge from entering the acceptor solution. Only a few microliters of 
SLM are required per sample, which provides a very low consumption of organic solvent. 
Compared to traditional LLE, the acceptor phase is aqueous and directly compatible with 
liquid chromatography. Organic solvent evaporation and reconstitution procedures are 
therefore not necessary. Also, EME can give faster extractions compared to HF-LPME. In 
HF-LPME, the extraction time is typically 30-60 minutes. In EME it is shorter, usually 5-20 
minutes (26). 
 
However, more research into several aspects of EME is needed (27). For instance, the 
selection of appropriate SLMs is a challenging and crucial part. For non-polar and basic 
substances, stable SLMs are available. 2-nitrophenyl octyl ether (NPOE) has been the 
predominant SLM since 2006, and is ideal for basic analytes with logPOCTANOL/WATER > 2. 
EME becomes more challenging with increasing polarity, due to limited partition into the 
SLM. 
 
Ionic carriers have been introduced to approach this problem, and they work by providing 
ionic interactions with the compounds to facilitate partitioning into the SLM (23). For 
moderately polar cationic analytes (0 < logP < 2), the ionic carrier bis(2-ethylhexyl) 
phosphate (DEHP) has successfully been added to NPOE to improve the extraction. However, 
highly polar analytes (logP < 0) have shown to be particularly difficult to extract using EME, 
and the results have generally been poor to modest.  
 
For acidic analytes, the most successful SLMs have been aliphatic alcohols, but they have 
shown to be less stable than NPOE in contact with biological fluids (27). Discovering new 
SLMs, especially for polar acidic analytes, is therefore a high priority in EME research. For 
EME to become a standard sample preparation method in TDM, it must be applied on 
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compounds with a variety of chemical properties. To date, most research has been on non-
polar, basic substances.    
 
  1.8 Aim of the study 
 
Methotrexate (MTX) is a highly polar and acidic analyte (28). This study will be an attempt to 
look deeper into an area of limited research, by applying different SLMs, donor solutions, 
acceptor solutions, and extraction parameters (voltage, time, agitation) to promote high 
extraction recoveries of MTX and its metabolites. This can contribute to the future application 
of EME in the extraction of a wide range of analytes with different physicochemical 
properties.   
 
The clinical approach to this thesis is related to the TDM of MTX. Today, protein 
precipitation is applied to samples from patients treated with glucarpidase. The method yields 
approximately 70% recovery, and limited sample cleanup that may result in matrix 
components remaining in the sample. In this study, EME will be used in an attempt to achieve 
higher extraction recoveries, and a cleaner extract containing MTX, DAMPA and 7-OH-
MTX. During EME method development, a HPLC-UV method will be used to quantify the 
recovery of MTX and its metabolites in the acceptor solution. For EME of spiked plasma 
samples, an LC-MS/MS method will be used for separation and quantification of the analytes, 







  2.1 Electromembrane extraction  
 
Electromembrane extraction (EME) is a microextraction technique based on the transfer of 
target analytes from a sample, through a supported liquid membrane (SLM), and into an 
acceptor solution (27). EME is a three-phase system: the sample and acceptor solutions are 
aqueous, while the SLM is an organic solvent. What distinguishes EME from previous SLM-
based extraction techniques, is that the driving force for mass transfer is an external electrical 
field, which facilitates electrokinetic migration of target analytes across the SLM. For 
extraction of basic substances (cations), the pH in the aqueous solutions is neutral or acidic, to 
keep the analytes in a protonated state. A negatively charged electrode (cathode) is located in 
the acceptor solution, and a positively charged electrode (anode) is located in the sample 
solution. The charged analytes are prone to electrokinetic migration towards the electrode of 
opposite charge. For extraction of acidic analytes (anions), the pH in the aqueous solutions is 
neutral or basic to keep the analytes negatively charged, and the direction of the electrical 
field is reversed. The choice of pH in the aqueous solutions is crucial, as EME may lead to 
pH-altering reactions, which in turn may affect extraction efficiency. This will be further 
discussed in section 2.2.1.  
 
An illustration of electromembrane extraction for acidic compounds is presented in Figure 6. 
In addition to the application of an electrical field, agitation of the EME system is essential to 
achieve fast extractions and high analyte recovery (29). This will ensure sufficient contact 





Figure 6. Principles of electromembrane extraction of acidic analytes. Adapted from (25). 
 
 
  2.1.1 Effects of electrolysis on electromembrane extraction 
 
As already mentioned, the pH must be adjusted to keep the analytes ionized in the donor and 
acceptor solution, ensuring influence of the electrical field. An important challenge in EME is 
the occurrence of electrolysis in the system. Cambridge dictionary defines electrolysis as “the 
use of an electric current to cause chemical change in a liquid” (30). The electrical current in 
EME is the sum of analyte and background ion migration across the SLM. It may influence 
the pH in the sample and acceptor solutions significantly, based on the following equations 
(24):  
 




+ (𝑎𝑞) + 2𝑒−  (Equation 1) 
Cathode:  2𝐻+(𝑎𝑞) + 2𝑒− → 𝐻2(𝑔)    (Equation 2) 
 
As a result, pH may decrease at the anode (equation 1) and increase at the cathode (equation 
2). The level of electrolysis is determined by extraction current and time.  
 
A consequence of electrolysis is reduced extraction recovery (31). When extracting acidic 
analytes, an increase in pH at the cathode is usually not a challenge because it will keep the 
analytes deprotonated in the donor solution. However, a gradual decrease of pH at the anode 
may prevent the analytes from maintaining their negative charge in the acceptor solution. As 
the analyte becomes neutral and is no longer influenced by the electrical field, diffusive back-
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extraction into the SLM may occur.  
 
Typical electrical currents in EME can range from a few units to tens of μA (32). They may 
even reach levels of hundreds of μA if ion carriers are added to the SLM to transfer polar 
analytes. The role of ionic carriers will be covered in the section on SLMs. The extraction 
current can be controlled by the applied voltage (24). It also depends on the chemical 
composition of the SLM, as the major electrical resistance is located in the SLM, and this is 
where the significant voltage drop occurs 
 
  2.1.2 The electrical double layer 
 
Another aspect related to the application of the electrical field, is the formation of electrical 
double layers at the aqueous solution/SLM interfaces (24). This may have a major impact on 
mass transfer in EME, and the phenomenon is illustrated below (Figure 7).  
 
 
Figure 7. Illustration of the electrical double layer in extraction of basic compounds. Adapted 
from (24). 
 
On application of the electrical field, a charge will build up within the SLM (24). When 
extracting basic compounds, positive charge will accumulate in the in the direction of the 
cathode, and negative charge will accumulate in the anode direction. This may, in turn, lead to 
a layer of elevated pH in the acceptor boundary layer due to the attraction of OH-. Thus, an 
electrical double layer is formed. The analytes will enter the SLM in a protonated state, but 
when entering the acceptor/SLM interface, they may become deprotonated and will no longer 
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be influenced by the electrical field. 
 
  2.1.3 General requirements for the supported liquid membrane  
 
The SLM is an organic solvent immiscible with water, typically comprising 5-25 microliters 
(27). It is immobilized by capillary forces in the pores of a porous polymeric membrane, 
which can be a flat sheet or a hollow fiber membrane. Choosing the optimal SLM for a 
particular analyte is one of the most important steps of EME. Different target analytes require 
different SLMs based on the chemical properties of the analyte. There are several 
physicochemical requirements for the SLM to facilitate efficient extractions.  
 
Ideally, the SLM should be insoluble, or have very low solubility in aqueous solutions (33). 
This is necessary to avoid leakage into the aqueous donor or acceptor solution. The water 
solubility of the SLM should not be higher than 1 g/L. The non-polar properties of the SLM 
allow high selectivity in terms of preventing polar sample matrix components from entering 
the acceptor solution (25).  
 
Furthermore, the viscosity of the SLM should be as low as possible, to maintain high 
permeability of the analytes migrating through the membrane (33). Keeping the viscosity low 
is also favorable for more practical reasons. It will facilitate the pipetting of the same amount 
of SLM to the porous polypropylene membrane.  
 
Finally, conductivity of the SLM should be low, but not zero (33). It is desirable to have 
efficient flux of analyte ions, and low flux of background ions and sample matrix ions across 
the SLM. A current exceeding 50 μA is generally not recommended in EME.  
 
  2.1.4  SLM for basic analytes 
 
For basic analytes, the main mechanism of solvation in the SLM is thought to be hydrogen 
bond interactions (33). Preferably, the SLM should have high hydrogen bond basicity, almost 
zero hydrogen bond acidity, and a logP value between 3 and 5.5. The most used SLM is 2-
nitrophenyl octyl ether (NPOE, see Figure 8). It has shown to be efficient in extraction of 




Figure 8. Chemical structure of NPOE. Downloaded from (34). 
 
As the structure shows, NPOE has two functional groups capable of hydrogen bond 
interactions: The nitrogen dioxide group contains two hydrogen accepting oxygen atoms, and 
the ether group contains one hydrogen accepting oxygen atom. 
 
NPOE is less efficient for extraction of polar basic substances with a logP < 1.5 (33) (Figure 
9). To increase extraction of these substances, it is possible to add another component to the 
SLM that acts as an ionic carrier. Di(2-ethylhexyl) phosphate (DEHP) is an example of such 
components (35). It is assumed that the negatively charged phosphate groups of DEHP are 
orientated towards the sample-membrane interface due to the electrical field. Polar basic 
substances from the sample are attracted to the negatively charged groups on DEHP, forming 
ion-pairs. This complex is sufficiently soluble in the SLM, which promotes transfer through 
the interface and into the SLM. The hydrophilic properties of the analytes will allow release 
to the acceptor solution. Non-polar analytes can form ion-pairs with DEHP and be transferred 
into the SLM as well, but since the complex is more hydrophobic, it prevents the analyte from 
being released to the acceptor solution. The addition of 5-25% DEHP to NPOE have proved 
to be successful for extraction of moderately polar analytes with a logP between 0 and 2 (23). 
For example, in the study of Hansen et al, EME of ephedrine (logP=1.3) with 10% DEHP in 
the SLM yielded over 90% recovery of the analyte. A challenge with DEHP is that it 
increases the current in the system, which makes EME more prone to electrolysis and pH 
changes (33).  
 




The pKa value of DEHP is approximately 1.94 (23). This suggests that the compound is 
mostly negatively charged at a pH value above 1.94.  
 
  2.1.5 SLM for acidic analytes 
 
The choice of SLM for acidic analytes is rather limited (33). One reason for this is that the 
interaction between acidic analytes and the SLM is not well understood. To be able to form 
hydrogen bond interactions with the analytes, the SLM should have a strong hydrogen bond 
acidity. Examples of such solvents are alcohols such as 1-octanol and 1-nonanol. Extraction 
efficiency usually decreases with increasing hydrocarbon chain length of the SLM ( > C8 ), 
due to increased viscosity (37). This makes it more difficult for the target analytes, especially 
hydrophilic, to migrate through the SLM.  
 
Very little research has been done on SLMs for polar and acidic analytes. One candidate ionic 
carrier, the cationic liquid substance Aliquat 336, was recently introduced for EME (38). It is 
a quaternary ammonium salt, with the nitrogen atom bound to one methyl group and three 
hydrocarbon chains of either C8 or C10. 
 
Figure 10. Chemical structure of Aliquat 336. Downloaded from (39). 
 
Aliquat 336 has a permanently positive charge on the nitrogen atom. This facilitates ion-pair 





  2.2 Chemical properties of methotrexate 
 
In order to succeed with EME, it is important to have a theoretical insight into the chemical 
properties of the analyte. That way, it becomes easier to facilitate optimal extraction 
conditions, such as the choice of pH in the aqueous solutions, and the composition of the 
SLM. MTX is an acidic and polar compound, with chemical properties implying several 
challenges to developing an EME protocol. The main chemical properties are listed in Table 
1.  
 
Table 1. Chemical formula, molar mass, logP and structure of Methotrexate (retrieved from 
Chemicalize (28)).  
Chemical formula C20H22N8O5 
Molar mass 454.447 g/mol 






One part of the MTX molecule consists of a pteridine ring residue, with two amine groups 
attached to the distal ring. The nitrogen atom between the two amine groups has a predicted 
pKa value of 2.8. As pH decreases below 2.8, an increasing fraction of MTX is protonated at 
this nitrogen atom. The pteridine ring structure is linked to a p-aminobenzoyl part, which is 
further linked to a glutamic acid residue. The glutamic acid contains two carboxylic acids, 





Figure 11. Predicted distribution of MTX (%) with different charge at pH 0-14 (retrieved and 
modified from (28)). 
 
In Figure 11, the green slope represents the percentage of MTX with a charge of -2. At pH 6 
and higher, nearly 100% of the molecules hold two negative charges, represented by the loss 
of a proton at each of the two carboxylic acid groups. At physiological pH (7.4), the amount 
of MTX carrying two negative charges is 99,96%. The distribution of MTX with a charge of -
1 is illustrated by the purple slope. This fraction dominates at pH 3.7. At pH 3, most of the 
MTX molecules are neutral, represented by the blue slope. Below pH 2.8, the MTX molecules 
containing one positive charge accounts for the biggest fraction, as shown by the pink line.  
 
MTX has a predicted logP value of -0,236, which is the partition ratio of MTX in octanol-
water. However, the log D value may be more relevant for EME, as this represents the 





Figure 12. Log D of MTX at pH 0-14. Retrieved from (28). 
 
MTX becomes more polar with increasing pH. This may cause difficulties in EME with 
regards to the partition of the analyte into the hydrophobic SLM.  
 
 
Figure 13. Solubility (mg/ml) at pH 0-14. Retrieved from (28). 
 
MTX has a predicted solubility of 0.51 mg/ml at pH 2. As Figure 13 suggests, the solubility 
of MTX greatly increases from pH 4 to pH 5.3. In the present study, standard solutions with a 
MTX concentration less than 0.01 mg/ml will be applied in EME, and the analyte will 
therefore most likely exist as dissolved molecules also in low pH conditions. In EME of MTX 
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as an anion, solubility will not be an issue, as the pH in solutions are 7.4 or higher.  
 
Nevertheless, the complex chemistry of MTX demands fine-tuned conditions in order to yield 
satisfactory recovery rates by means of EME extraction, in accordance with the description of 
the EME technique.  
 
  2.2.1 Chemical properties of the metabolites 7-OH-MTX and DAMPA 
 
7-OH-MTX is the hydroxylated metabolite of MTX. It highly resembles the parent analyte, 
differing only by an additional OH-group (Figure 14).  
 
Figure 14. Chemical structure of 7-OH-MTX.  
 
The chemical structure of 7-OH-MTX suggests that it behaves similarly to MTX in terms of 
log D, solubility and pKa values. However, the additional OH-group might increase the 
polarity of the analyte.  
 





Figure 15. Chemical structure of DAMPA.  
 
The loss of the glutamic acid from MTX might alter the chemical properties of DAMPA, 
making it less polar. Nevertheless, a carboxylic acid remains, and there are reasons to believe 
that it can be at least as good candidate for EME as MTX and 7-OH-MTX. Due to the 
presumably reduced polarity of DAMPA, its partition into the SLM could increase.   
 
  2.3 High-performance liquid chromatography 
 
High-performance liquid chromatography (HPLC) is the most common chromatographic 
technique used to quantify and identify analytes in biological samples (10). All 
chromatographic methods are based on the separation of different compounds in a sample 
(41). In HPLC, the sample is injected into the instrument and mixed with a liquid. This liquid 
is called the mobile phase, and it is used to transport the injected sample through a separation 
column. A pump ensures that the mixture of sample and mobile phase is delivered to a 
column at a constant flow rate. The column is packed with a non-moving solid, called the 
stationary phase. Its function is to slow down or retain compounds. If the sample contains 
several different compounds, the stationary phase may retain these differently, and they will 
elute from the column at various rates. The time it takes for a compound to elute from the 
column is called the retention time, which is determined by the compound’s distribution 
between the mobile phase and stationary phase. After elution, a detector can be used for 





Figure 16.  Illustration of the main components in HPLC. 
 
 
  2.3.1 Reversed phase liquid chromatography 
 
In reversed phase liquid chromatography, the stationary phase is hydrophobic (42). It 
typically contains hydrocarbon groups bound to silanol groups on silica particles. C18 
(octadecyl) is the most commonly used group, but C8 (octyl) and phenyl groups are also 
common. The retention of compounds is mainly based on van der Waals forces with the 
hydrocarbon chains on the stationary phase. Thus, hydrophobic compounds will have longer 
retention times than hydrophilic or polar analytes. The separation efficiency of the column is 
characterized by high peak resolution and short run time (43). The efficiency increases with 
decreasing size of the silica particles. Smaller particles provide a more uniform flow through 
the column, and the eluting peaks will appear narrower in the chromatogram. The optimum 
flow rate is higher for small particles than for larger particles, which allows shorter run time. 
However, smaller particles gives higher back pressure in the column. The pump must 





Figure 17. Principles of reversed phase liquid chromatography.  
 
The mobile phase in reversed phase HPLC is an aqueous solution, consisting of water and 
organic solvents that are miscible with water (42). The organic solvents are typically 
methanol, acetonitrile, or tetrahydrofuran. The elution strength of an organic solvent reflects 
the ability to compete with the analyte’s place on the stationary phase. Shortening the 
retention time of the analytes, tetrahydrofuran possesses the highest elution strength, followed 
by acetonitrile and methanol. A mobile phase consisting of 60% methanol in water has the 
same elution strength as 46% acetonitrile in water, or 37% tetrahydrofuran in water (44). 
Although methanol is less expensive and toxic than acetonitrile, it can form a more viscous 
mixture in water, increasing the back pressure in the HPLC system. Acetonitrile forms less 
viscous mixtures with water. The mobile phase must be chosen carefully to obtain the best 
results in HPLC (10). The solvents should preferably not give any response in the chosen 
detector, and must therefore have a high degree of purity. 
 
The pumping system can deliver the mobile phase by combining solvents from up to four 
different reservoirs (10). The composition may be constant (isocratic) or composed in a way 
that ensures gradual increase of the eluting strength of the mobile phase during 
chromatography (gradient elution). Gradient elution can be applied for earlier elution of 
hydrophobic analytes, resulting in higher and sharper peaks in the chromatogram, and 
improved detection limits.  
 
The pH in the mobile phase plays an important role when separating acids and bases (42). The 
retention time is reduced with increasing ionization of the analyte. The pH should be chosen 
to avoid variation in retention time due to small changes in the composition of the mobile 
phase. The analyte should be either fully ionized or neutral. To achieve this, the pH value of 
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the mobile phase should not be too close to the pKa value of the analyte. Also, when using 
silica packed columns, the pH in the mobile phase must usually be within the range of 2 - 8. 
With pH higher than 8, the silica can dissolve. With a pH lower than 2, the functional groups 
can be cleaved off the silica particles.  
 
Liquid chromatography is a separation method that offers many advantages in bioanalysis 
(45). The sample can be precisely injected into the system by an autosampler, ensuring that 
the same volume is injected each time. The columns can be changed to adjust to the analyte 
selectivity. There is less risk of sample degradation since heating is not required, which can be 
a problem in gas chromatography. There is a high degree of automation of HPLC, because the 
whole process can be controlled by a computer system (10). The detector will provide an 
electronic response to the compounds, that can be used by the computer system to calculate 
the quantity of a compound. 
  
  2.4 UV detection  
 
After separation in HPLC, analytes can be detected and measured by ultraviolet (UV) 
spectroscopy (10). This is a technique based on the analytes’ absorption of UV light. To be 
capable of detection, the analyte of interest must contain a chromophore, which is a part of the 
molecule able to absorb UV radiation in the wavelength range of 190-400 nm. To contain a 
chromophore, at least one double bond must be present in the molecule. The absorption of 
radiation energy is achieved if the analyte excites electrons from a ground state to a state of 
higher energy. The amount of energy that is required to excite the electrons corresponds to a 
certain wavelength, ranging from 190 to 400 nm. Sigma bond (σ) electrons typically requires 
energy that corresponds to a wavelength below 200 nm, whereas double bond (π) electrons 
excite more easily and will result in UV absorbance above 200 nm. According to the 
molecular structure, analytes will therefore absorb energy at different wavelengths.   
 
The Beer-Lambert law describes the principle of light absorption (46):  
𝐴 = 𝜀 ∗ 𝑏 ∗ 𝑐 
Where A is the absorbance, which is a measure of the amount of light absorbed by the 
analyte. A is defined as the logarithm of the intensity of incident radiation divided by the 
intensity of transmitted radiation. ε is a constant called the molar extinction coefficient, based 
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on the absorbance of a 1 M solution of the analyte. C is the concentration of the analyte in 
moles/L. b is the pathlength of the flow cell in cm. The flow cell contains the eluent from the 
LC column, with a typical length of 6-60 mm and volume of 6-10 µl (10). 
 
Commonly, the radiation source in UV spectroscopy is a deuterium lamp, which emits light in 
the entire UV range (10). This type of radiation is called polychromatic radiation. In a simple 
wavelength UV detector, a monochromator will ensure that UV radiation with the correct 
wavelength is directed through the flow cell, containing the eluent from the LC column. A 
diode array detector (DAD) is another type of UV detector, where the entire polychromatic 
radiation from the deuterium lamp is passed directly through the flow cell (47). The 
transmitted light is then spread into separate wavelengths by a fixed grating, and detected by 
an array of diodes that monitors the intensity of light at each wavelength. This offers several 
advantages, such as a recording of the full UV-spectrum of the analyte, which is useful in 
identification if the analyte is unknown (10). Selected wavelengths can also be chosen to 
detect each analyte in a sample at the wavelengths with highest molar absorption. For optimal 
detection sensitivity, analytes should be measured at their maximum UV-absorbance. 
 
 
Figure 18.  Illustration of diode array detection (DAD). Retrieved from (47). 
 
UV spectroscopy is a beneficial detector for many reasons (47). It is easy to use, with a high 
precision (<0,2% relative standard deviation (RSD)) and provides information on peak 
identity by using diode array detection (DAD). However, it is not always the best choice in 
bioanalysis. Sensitivity issues may occur if the analyte exists in very low concentrations, 
which is typical in biological fluids (10). The lower limit of detection of the UV instrument 
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may therefore not be low enough to detect the analyte. In other cases, UV detection may not 
be sufficiently selective if closely related compounds absorb UV radiation at similar 
wavelengths. 
 
  2.5  Mass spectroscopy detection 
 
Mass spectroscopy (MS) detection provides more information about the molecular structure 
of an analyte than UV detection, and it has a high selectivity and sensitivity (10). MS 
detection has therefore become a method of choice in bioanalysis. Compared to UV-
spectroscopy, where detection is based on the analytes’ absorption of UV light, MS detection 
requires information of ionized analytes to provide a signal. Liquid chromatography coupled 
with mass spectrometry (LC–MS) is currently the preferred instrumental technique for 
bioanalysis of pharmaceuticals (12).  
 
Mass spectrometry in LC-MS can be divided into three sections (10). First, the analytes are 
ionized and transferred to a gas phase. This occurs in the coupling between LC and MS, 
called the interface. Second, a mass analyzer separates the ions based on their mass-to-charge 
(m/z) ratio, which is the ratio between the exact mass of the analyte and the number of 
charges of the analyte. Third, the ions are detected based on a generated current. 
 
Electrospray ionization (ESI) is a common ion generator in LC-MS used to ionize polar 
compounds (10). In ESI, the eluent from the LC column passes through a capillary needle, to 
which a high electrical potential is applied (48). If the electrical potential is positive, negative 
ions will be attracted to the needle, and the positive ions will be free to leave it. A flow of 
nitrogen gas outside of the needle will assist in the evaporation of the positively charged 
droplets. The droplets disintegrate due to charge-charge repulsion until they exist as gas phase 
ions. The positively charged ions are attracted to the negatively charged inlet of the mass 
spectrometer, called a heated capillary. This is a channel that leads into the mass analyzer, 





Figure 19. Illustration of the electrospray ionization process. Adapted from (48). 
 
There are several types of mass analyzers used for ion separation, and a triple quadrupole 
mass analyzer is commonly used in bioanalysis (10). It consists of two quadrupole mass 
analyzers and a collision cell. One single quadrupole consists of four rods placed parallel to 
each other, where the opposite pairs are electrically connected. Direct current (DC) and a 
radio frequency (RF) are applied to one pair, and the opposite DC and RF are applied to the 
other pair. This will create an oscillating, electrical field. The generated ions will move inside 
this field, and specific combinations of DC and RF will allow the ion of interest to pass the 
quadrupole stably. Other ions will collide with the quadrupole and be trapped. It is the m/z 
ratio of the ion that decides what DC and RF combinations that makes the ion move stably. 
Following the passage through the first quadrupole, the filtered ions will enter another 
quadrupole called a collision cell. It contains an inert gas that collides with the ions on their 
way towards the exit of the collision cell. The collision will cause fragmentation of the ions 
into smaller ions, which will further be transferred to the third quadrupole. Here, the 
fragmented ions are separated by the same principle as in the first quadrupole. The 
fragmented, filtered ions will reach a detector at the end of the third quadrupole.  
 
 




The function of an ion detector in MS is to measure the presence of an ion (10). In general, 
detection is based on the impact of an ion on a surface, which will generate a measurable 
current. Several different ion detectors exist, but an electron multiplier is one of the most 
common types, and is used for this study. Here, ions will collide with an emissive material 
that causes the release of electrons. A series of dynodes multiplies the number of electrons by 
105, before the electrons arrive at the anode where the current is measured (49). 
 
One of the major challenges in LC-MS analysis of biological samples is so-called matrix 
effects (10). This refers to the impact of biological components, such as lipids and peptides, 
that are extracted concomitantly with the analyte of interest during sample preparation. These 
effects may suppress or elevate the signal intensity of analytes, and occur when matrix 
components elute at the same retention time as the analytes. The mechanism for signal 
suppression is not completely understood, but there are two main explanations: 
1. During the electrospray ionization process, there is an altered desorption of ions from 
the droplet surface.  
2. Matrix components compete with the analyte for charges.  
A common way to check for matrix effects is called post-extraction addition (10). First, a 
blank biological sample is prepared using the chosen sample preparation method. A fixed 
amount of analyte is added to the extract, and the sample is analyzed on LC-MS. Then, the 
same amount of analyte is added to a solvent or buffer that does not contain biological fluids. 
This sample is analyzed by LC-MS, and the results from the two samples are compared. 
 
The internal standard (IS) method is a valuable technique in bioanalysis (50). An IS is a 
known quantity of a compound that is added to the unknown analyte in a sample. The signals 
from the IS and the unknown analyte are compared to find the amount of unknown analyte 
that is present in a sample. The IS must have similar physicochemical properties as the target 
analyte, but not to the degree that it cannot be determined accurately (51). In LC-MS, 
isotopically labeled versions of the analyte are the most ideal candidates, and they can be 
distinguished from the target analyte by having a higher m/z ratio. 
 
Addition of an IS is useful if the quantity of injected sample, or if the instrument response 
varies from run to run (50). For example, a change in flow rate may increase the signal from 
an IS by 5%, but the same increase in signal will also be observed from the analyte. The 
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relative response of the analyte and the IS is therefore constant. This differs from a calibration 
curve without IS, which is only accurate for the current set of conditions. An IS can also be 
applied when sample loss may occur during sample preparation. The ratio of IS and analyte is 
constant because the same amount is lost from each during the process. 
 
3 Experimental  
 
  3.1 Chemicals  
 
Table 2. List of chemicals, their purity, and producer.  
Chemical Purity Producer 
Water  Milli-Q quality Millipore (Burlington, MA, USA) 
Hydrochloric acid (HCl) 37% Sigma-Aldrich  
(Steinheim, Germany) 
 
Potassium hydroxide (KOH)  >85% 
Sodium hydroxide (NaOH) >97% 
2-Nitrophenyl octyl ether  
C14H21NO3) 
>99% 






Trifluoroacetic acid (C2HF3O2) >99% 
1-Nonanol (C9H20O) 98% 
L-Menthone (C10H18O) >96% 
Menthol (C10H20O) 99% 
Phosphate buffered saline tablet  
Sodium phosphate monobasic 98% 
Methanol (CH3OH) >99.9% 
Formic acid (CH2O2) >95% 










Potassium dihydrogen phosphate 
(KH2PO4) 
>99.5% 
Di-sodium hydrogen phosphate 
(Na2HPO4) 
99.5% 
1-Octanol (C8H18O) >99% 
Sodium hydrogen carbonate 
(NaHCO3) 
99.5% 
Potassium nitrate (KNO3) 99% 
Methanol (CH3OH) Hypergrade for 
LC-MS 
Acetonitrile (CH3CN) Hypergrade for 
LC-MS 
Acetonitrile (CH3CN) Gradient grade 
for liquid 
chromatography 
Aliquat 336  Unknown Obtained from the Department of 
Pharmacy, University in Oslo  
Bis-(2 ethylhexyl)amine Unknown Obtained from the Department of 
Pharmacy, University in Oslo 
Ammonium hydroxide 
(NH4OH)  
74 mM Stock solution obtained from the 
lab 
Peppermint oil Pharmaceutical 
grade 
Farmagon AS (Oslo, Norway) 
Silver nitrate (AgNO3) 99.8% VWR International AS (Oslo, 
Norway) 








Table 3. Analytes extracted with EME. 
Analyte Formulation Producer 
Methotrexate 50 mg/2 ml MTX in 
sodium chloride, 
sodium hydroxide (for 
pH adjustment) and 
water for injection.   




1 mg 7-OH-MTX 
sodium salt 
Cayman Chemical Company (Ann 
Arbor, MI, USA) 
Methotrexate impurity E 
CRS, Catalogue code: 
Y0000664 (DAMPA) 
10 mg  European Directorate for the 
Quality of Medicines & 




  3.2 Solutions 
 
Table 4. Preparation of solutions for EME experiments. 
Solution Preparation 
200 ml 20 mM phosphate 
buffer, pH 2.6 
0.544 g KH2PO4 was weighed and added to 160 ml Milli-
Q water. The pH was adjusted to 2.6 with 37% HCl. Milli-
Q water was then added to a final volume of 200 ml.  
200 ml 40 mM potassium 
phosphate buffer, pH 7.4 
969 mg K2HPO4 and 331 mg KH2PO4 was weighed and 
dissolved in 160 ml Milli-Q-water. The pH was adjusted to 
7.4 with a 1 M KOH solution. Milli-Q water was then 
added to a final volume of 200 ml (52).  
200 ml 40 mM sodium 
phosphate buffer, pH 7.4 
1617 mg Na2HPO4 and 271 mg NaH2PO4 was weighed 
and dissolved in 160 ml Milli-Q-water. The pH was 
adjusted to 7.4 with a 50 mM NaOH solution. The buffer 




Phosphate buffered saline  1 PBS tablet was dissolved in 200 ml Milli-Q-water.  
50 mM HCl, pH 1.3 37% HCl was gradually added to Milli-Q water until the 
pH was 1.3.  
Standard solution of 8 and 5 
µg/ml MTX in phosphate 
buffer pH 7.4 
6.4 µl 25 mg/ml MTX was added to 20 ml phosphate 
buffer pH 7.4, generating a 8 µg/ml MTX standard 
solution. 
 
4 µl 25 mg/ml MTX was added to 20 ml phosphate buffer 
pH 7.4, generating a 5 µg/ml MTX standard solution. 
SLM containing Aliquat 
336.  
Aliquat 336 is a highly viscous solution. To ensure the 
right concentration, the amount of aliquat 336 was 
measured by weight rather than volume. Aliquat 336 has a 
density of 0.88 g/mL (54). To prepare a 1 ml 1% aliquat 
solution, 8.8 mg Aliquat was weighed and mixed with 990 
µl SLM.  
Menthol/menthone SLM Menthol was measured by weight, due to its solid state. 
The compound has a density of 0.904 g/ml (55).  
 
For a 75% (w/v) menthol in menthone mixture, 1356 mg 
menthol was mixed with 0.5 ml menthone.  
 
For a 50% (w/v) menthol in menthone mixture, 904 mg 
menthol was mixed with 1 ml menthone.  
DAMPA stock solution 
(630.4 µM) 
2.4 mg DAMPA was dissolved in 10 ml methanol, 
generating a 0.24 mg/ml solution. 0.5 ml was removed 
from the solution. 1.5 ml 74 mM ammonium hydroxide 
was added to the remaining 9.5 ml. The new concentration 
of DAMPA was 0.207 mg/ml, or 630.4 µM. 
7-OH-MTX stock solution 
(1061.1 µM) 
1 mg of the analyte was dissolved in 2 ml methanol and 
distributed to 10 separate vials, generating 0.5 mg/ml (or 
1061.1 µM) stock solutions.  
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Plasma spiked with 10 µM 
MTX.  
 
36 µl of 550.12 µM MTX stock solution in phosphate 
buffer pH 2.6 was mixed with 1964 µl plasma. The 
mixture was left in 10 minutes to ensure the establishment 
of protein binding equilibrium. 2000 µl phosphate buffer 
2.6 was then added to the mixture. The pH was 6.89 due to 
the strong buffer capacity of plasma. The mixture was 
therefore pH adjusted with HCl to 2.6, and the final 
volume was 4555 µl. Hence, the new concentration of 
MTX was 4.39 µM.  
4.39 µM MTX standard 
solution for LC-MS analysis 
of plasma MTX.  
200 µl plasma was diluted with 200 µl phosphate buffer 
pH 2.6. The pH was adjusted to 2.6 with 37% HCl. The 
mixture was extracted according to the relevant procedure, 
and 192 µl extract was spiked with 7.8 µl of 110 µM MTX 
stock solution in methanol.  
Donor solution containing 
physiological concentration 
of bicarbonate 
Normal concentration range of bicarbonate in serum is 23-
30 mM (56). NaHCO3 has a molar mass of 84,01 g/mol. 
42 mg NaHCO3 was dissolved in 20 ml Milli-Q water, 
generating a 0.025 M (25 mM) solution.   
Donor solution containing 
3.4 mg/ml of the cationic 
carrier bis-(2 ethylhexyl) 
amine (BEA).  
The density of BEA is 0.8 g/ml (57). For preparation of 1 
ml solution containing 3.4 mg/ml BEA, 4.2 µl BEA was 
mixed with 40 mM potassium phosphate buffer.  
 
 
  3.3 Lab equipment  
 
Table 5. General lab equipment.  
Equipment Description Producer 
pH meter pH Meter 744 Metrohm AG (Herisau, Switzerland) 
pH electrode LL Biotrode 3 mm Metrohm AG (Herisau, Switzerland) 




Mixer/heater Thermomixer Comfort Eppendorf (Hamburg, Germany) 
Centrifuge Allegra™ X-22R 
Centrifuge 
Beckman Coulter (Brea, CA, USA) 
Weight AG204 DeltaRange® Mettler Toledo (Greifensee, 
Switzerland) 
Pipettes  Finnpipette® (200-1000 
µl, 0.5-10 µl, 20-200 µl, 
and 5-50 µl) 
Thermo Labsystems (Thermo Fisher, 
(Waltham, MA, USA)) 
 
Pipette tips  1000 µl, 200 µl and 10 
µl 
VWR (Radnor, PA, USA) 
Tubes SafeSeal micro tube 
(1.5 ml and 2.0 ml) 
Sarstedt Ag & Co. KG (Nümbrecht, 
Germany) 
 
Vials for standard 
solutions 
20 ml LSC vials PerkinElmer (Waltham, MA, USA) 
 
 
Table 6. Equipment used for HPLC and LC-MS. 
Equipment Description Producer 
Septum for HPLC 8 mm silicone septum VWR (Radnor, PA, USA) 
Screw cap for HPLC PP black 8 mm centre 
hole 
VWR (Radnor, PA, USA) 
Vials for HPLC Screw vial 1.5 ml, 
32x11.6 mm clear 
VWR (Radnor, PA, USA) 
Inserts for HPLC Micro insert 0.1 ml 
30x5 mm clear 
VWR (Radnor, PA, USA) 
Screw cap for LC-MS 9 mm screw caps with 
septum 
Aligent Technologies (Santa Clara, 
CA, USA) 
Vials for LC-MS 2 ml vials Aligent Technologies (Santa Clara, 
CA, USA) 
Inserts for LC-MS 250 µl polypropylene 
inserts 




  3.4 EME equipment and setup  
 
The vials containing the aqueous solutions in EME are made of a black, electrically 
conductive polymer, and can hold volumes up to 600 µl. One of the vials serves as the donor 
vial, and the other as the acceptor vial, and they are connected by a plastic union (Figure 21). 
A porous polypropylene (PP) Accurel® flat sheet membrane is positioned in a narrow groove 
in the middle of the union, with a function of holding the supported liquid membrane (SLM). 
The vials and unions were obtained from G&T Septech AS (Ski, Norway), and the PP-
membranes are produced by 3M (Membrana) (Wuppertal, Germany).  
 
 
Figure 21. Donor and acceptor vial (black) connected by a union (white). 
 
The assembled unit of the vials and the union is placed upon the sample holder, which is 
attached to a DLAB MX-M agitator (DLAB Science Co. ltd., China), with a programmable 
agitation in the range of 0-1500 RPM. A top cover with ten pairs of electrodes is positioned 
over the assembly, and screws are used to secure contact between the electrodes and the 
assembly. The equipment allows simultaneous extraction of ten samples. The conductive 
material of the vials maintains the electrical field, delivered by an external DC power supply 
model ES 0300-0.45 from Delta Power supplies (Delta Elektronika, Zierikzee, the 
Netherlands) via the electrodes in the top cover. This differs from traditional EME, where 
electrodes are immersed into the donor/acceptor solutions. The power supply has an 
adjustable voltage in the range 0-300 V. A Fluke 289 multimeter (Fluke Corporation, Everett, 





Figure 22. EME equipment setup.  
 
  3.5 EME procedure  
 
A schematic illustration of the EME procedure is showed in Figure 23. Firstly, the precut PP-
membrane was placed inside the union. This was achieved by using the bottom of a pipette tip 
to carefully push the membrane in place. Secondly, acceptor solution was pipetted into the 
acceptor vial, and donor solution was pipetted into the donor vial. In the present study, all 
experiments were performed with 250 µl donor and acceptor solutions. Gloves were used 
when handling the vials, to avoid fingerprints that could impair conductivity. The union, 
containing the PP-membrane, was attached to the acceptor vial. These two parts were 
connected as tightly as possible, but without crumpling the PP-membrane. If the assemblance 
is too loose, the aqueous solutions might leak around the SLM, which could result in poor 
reproducibility of the extractions. Next, SLM was pipetted onto the PP-membrane. 10 µl SLM 
was applied throughout the study. The acceptor vial + union complex was attached to the 
donor vial. When extracting cationic substances, the donor compartment was placed in the 
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direction of the positive electrode, and the acceptor compartment was placed in the direction 
of the negative electrode. The direction was reversed when working with anions.  
 
 
Figure 23. Principle of the EME procedure. 
 
Prior to analysis of the extracted samples on HPLC, the donor and acceptor vials were 
centrifuged on a Concentrator plus 5305 centrifuge (Eppendorf, Hamburg, Germany). This 
was to remove air bubbles at the bottom at the built-in inserts of the vials.  
 
As mentioned earlier, the extraction current could be observed and recorded using a 
multimeter during EME. This would give a real time indication of extraction stability and 
efficacy. If the current was too low, electrokinetic migration of the analyte usually happened 
to a minimal degree. If the current was too high, it could lead to instability, electrolysis, and 
subsequent pH changes in the aqueous solutions. Figure 24 shows an example of a stable 
current curve in EME from experiment 19. A typical curve has a sharp decrease for the first 





Figure 24. Example of an extraction current curve in EME (experiment 19).  
 
  3.6 HPLC-UV method development  
 
For separation and detection of MTX and its metabolites 7-OH-MTX and DAMPA, a Hitachi 
Chromaster HPLC instrument was used, produced by Hitachi High-Tech Science Corporation 
(Tokyo, Japan). HPLC-UV analysis was applied to all experiments involving EME of MTX, 
7-OH-MTX and DAMPA from standard buffer solutions. The extracts from spiked plasma 
samples were analyzed using LC-MS/MS.  
 
Table 7. HPLC instrument components overview. 
Component Description 
Detector Hitachi Chromaster 5430 Diode Array 
Detector 
Auto Sampler Hitachi Chromaster 5260 Auto Sampler 
Pump Hitachi Chromaster 5160 Pump 
Degasser Merck L-7614 (Merck Millipore 























Column Purospher® STAR RP-18 endcapped. 3 μm 
particle size, 55 mm x 4 mm.  
LiChroCART® Cartridge set (Supelco 
(Bellefonte, PA, USA).  
Software Chromaster system manager version 2.0 
 
 
  3.6.1 Establishment of gradient elution of MTX and 7-OH-MTX 
 
To obtain sharp peaks and short retention times, gradient elution was applied to the method 
with a combination of two mobile phases. Mobile phase A consisted of Milli-Q water with 
0.05% trifluoroacetic acid (TFA). Mobile phase B consisted of acetonitrile (ACN) with 0.05% 
TFA. A sample containing 250 μg/ml of MTX was used for development of the HPLC-
method gradient. The flow rate was set to 1.2 ml/min. The initial gradient is listed in Table 8.  
 
Table 8. Initial HPLC gradient for the elution of MTX.   
Time 
(min) 
% A (Milli-Q water + 
0.05% TFA) 
%B (ACN + 0.05% 
TFA) 
0 60 40 
5 20 80 
6 60  40  
7 60 40 
 
After running the sample using the initial gradient, the chromatogram showed the elution of 
MTX almost immediately after injection. The composition of mobile phases was changed to 
initially contain more Milli-Q water, resulting in less competition from the mobile phase on 
the place on the stationary phase. Also, the amount of organic solvent was increased from 
70%-80% over the course of a minute, to ensure that possible contaminants would become 







Table 9. Final HPLC gradient for the elution of MTX. 
Time 
(min) 
% A (Milli-Q water + 
0.05% TFA) 
%B (ACN + 0.05% 
TFA) 
0 95 5 
5 30 70 
6 20 80 
7 95  5  
8 95 5 
 
The peak identifying MTX in this chromatogram was satisfactory, with a retention time of 2.9 
minutes. 7-OH-MTX had the same retention time. The metabolite differs from MTX by 
containing an extra OH-group, making it slightly more polar than MTX. In theory, it would 
therefore elute faster than MTX if the gradient allowed it. However, the LC-MS method in 
section 3.7 was developed with the purpose of being able to detect all three metabolites.  
 
A monitoring wavelength at 300 nm was chosen, because MTX and 7-OH-MTX had the 
strongest absorption of UV-light at this value during method development. Both compounds 





Figure 25. Chromatogram showing the elution of 10 μl 5 μg/ml MTX at 2.9 minutes.  
 
A standard curve was developed, to establish the lower limit of detection and linearity. A 
sample of 250 μg/ml MTX was diluted with a mixture of water and ACN (95:5) 16 times, 
making the next sample half the concentration of the previous sample.  
 





250  3 514 707 
125 1 981 605 
63 1 031 105 
32 527 181 
16 265 083 
8 132 763 
4 66 462 
2 33 176 
1 16 704 
0.5  8753 
0.25 4137 
0.125  1920 
0.0625  1196 








Figure 26. Standard curve of 10 μl 0.0078 - 1 μg/ml MTX. 
 
 
Figure 27. Standard curve of 10 μl 2 - 250 μg/ml MTX.    
 
Below a concentration of 0.0313 μg/ml MTX, the standard curve was no longer linear. The 
chromatograms displayed small and broad peaks, and the area under the peak could not be 
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calculated accurately. At 0.0039 μg/ml MTX and below, no MTX was detected. Also, the 
curve flattened out between 125 and 250 μg/ml. In conclusion, the standard curve was linear 
in the range of 0.0313- 125 μg/ml. The trendline for the linear area has the equation y=15943x 
+ 4119. 
 
A sample of 100 μg/ml 7-OH-MTX was analyzed on HPLC and compared to the standard 
curve of MTX. When plotting the absorbance value of 10 μl 100 μg/ml 7-OH-MTX 
(1 278 778) into the equation for the linear trendline of MTX, x became 80 μg/ml. The reason 
why it was not 100 μg/ml was unclear, but could be that the compound was not sufficiently 
dissolved in methanol during preparation of the standard solution before distribution into 
separate vials (Table 4). Nevertheless, the HPLC-UV method was satisfactory for both MTX 
and 7-OH-MTX for the purpose of the development of an EME protocol.   
 
Table 11. HPLC-UV parameters for the separation and quantitation of MTX and 7-OH-MTX. 
Parameter Value 
Flow rate 1.2 ml/min 
Run time 8 minutes 
Mobile phase A Milli-Q-water + 0,05% trifluoroacetic acid (TFA) 
Mobile phase B Acetonitrile (ACN) +  0,05% trifluoroacetic acid (TFA) 
Injection volume 10 µl 






  3.6.2 HPLC-UV method development for quantitation of DAMPA 
 
The method for quantitation of MTX and 7-OH-MTX in section 3.6.1 did not apply for the 
metabolite DAMPA. No peaks appeared in the chromatogram when analyzing a sample 
containing this metabolite. This was somehow unexpected, since the analytes resemble in 
structure by containing the same ring structures (Figure 14 and 15). However, the loss of the 
glutamic part may have made DAMPA an unfitting candidate for the method developed for 




Thus, a different column was applied for the separation of DAMPA. This was a 5 cm x 2.1 
mm Ascentis® Express Phenyl-Hexyl column (Supelco (Bellefonte, PA, USA), with a 
particle size of 2.7 µm. The reason why this column was chosen, was that phenyl hexyl 
columns are beneficial for the purpose of separating aromatic compounds. Methanol was 
chosen as mobile phase instead of ACN, because it more easily breaks π-π interactions 
between aromatic compounds and the stationary phase, facilitating a faster elution of the 
analyte (58). 
 
The flow rate in this method was adjusted downwards due to the reduction in internal 
diameter of the column. The C18 column had an internal diameter of 4 mm, while the phenyl 
hexyl column had an internal diameter of 2.1 mm. Keeping the same flow rate would most 
likely make the analyte elute too fast. In this method, 0.3 ml/min was applied, consequently 
leading to increased analysis time.  
 
Table 12. HPLC gradient for the elution of DAMPA. 
Time 
(min) 
% A (Milli-Q water + 
0.05% TFA) 
%B (Methanol + 
0.05% TFA) 
0 90 10 
8 25 75 
9 90 10 
15 90 10  
 
 Table 13. HPLC-UV parameters for the separation and quantitation of DAMPA. 
Parameter Value 
Flow rate 0.3 ml/min 
Run time 15 minutes 
Mobile phase A Milli-Q-water + 0,05% trifluoroacetic acid (TFA) 
Mobile phase B Methanol +  0,05% trifluoroacetic acid (TFA) 
Injection volume 5 µl 








Figure 28. Chromatogram showing the elution of DAMPA at 8.3 minutes.  
 
  3.7 LC-MS/MS method development 
 
An LC-MS/MS method for identification and quantification of MTX, 7-OH-MTX and 
DAMPA was developed using the instrument described in Table 14. The method was 
intended for analysis of plasma samples spiked with MTX and extracted by EME.  
 
Table 14. LC-MS instrument components overview. 
Component Description Producer 




LC binary pump Aligent 1100 G1312A Aligent Technologies 
(Santa Clara, CA, USA) LC autosampler Aligent 1100 G1367A 
LC column oven Aligent 1100 G1316A 
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Column Kromasil 100-5-C18  
2.1 × 100 mm 
AkzoNobel (Amsterdam, 
The Netherlands)  






  3.7.1 LC parameters and gradient for the separation of MTX, 7-OH-MTX 
and DAMPA   
 
The gradient applied for the elution of the MTX, 7-OH-MTX and DAMPA in the LC-MS/MS 
method was similar to the one for the HPLC-UV method (section 3.6.1), with an initial high 
percentage of Milli-Q water followed by an increasing amount of ACN up to 90% (Table 15).   
 
Table 15. Composition of mobile phase gradient for the elution of MTX, 7-OH-MTX and 
DAMPA. 
Time (min) %A (Milli-Q water + 
0.01% formic acid) 
%B (ACN + 0.01% 
formic acid) 
0 90 10 
5 10 90 
6 10 90 
6.1 90 10 
10 90 10 
 
Table 16. Instrumental conditions for LC separation of MTX, 7-OH-MTX and DAMPA.  
Parameter Description 
Flow rate 250 µl/min 
Run time 10 minutes 
Column temperature 35 °C 
Injection volume 1 µl 
 
The retention times for MTX, 7-OH-MTX, and DAMPA were 3.7, 4.2, and 4.2 minutes, 
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respectively (Figure 29). 7-OH-MTX and DAMPA could not be sufficiently separated by the 
chromatographic method. However, MS/MS detection made it possible to identify and 
quantify each metabolite.  
 
 
Figure 29. Chromatogram showing the elution of 1 μl 0.212 µM MTX, 0.212 µM DAMPA 
and 1.33 µM 7-OH-MTX.  
 
When analyzing samples containing only MTX, the retention time was approximately four 
minutes. However, when analyzing MTX in a mixture with the other metabolites, it eluted 
earlier. This can be explained by instrumental variations such as a small change in mobile 
phase composition or flow rate, or interference from the other metabolites in the solution or 
with the stationary phase.  
 
  3.7.2 MS/MS method development for detection and quantification of 
MTX, 7-OH-MTX and DAMPA  
 
A multiple reaction monitoring (MRM) scan type was applied, which is a common technique 
for triple quadrupole MS (59). In the first quadrupole, the precursor ion/target analyte is 
selected and reaches the collision cell, where it undergoes fragmentation. One (or several) of 
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the fragmented daughter ions can be selected to flow through the third quadrupole, while 
other ions are excluded.  
 
The LC-MS/MS method applied electrospray ionization in positive mode for generation of the 
precursor ions before entering the first quadrupole. The ion spray voltage was 3500 V, and the 
temperature in the ion source was 450 °C.  
 
The MS/MS conditions in Table 17 were adjusted for MTX only, assuming that the method 
would be applicable to the other two metabolites. A solution of 1 µM MTX was injected 
directly into the MS/MS for determination of the best values for each parameter. The values 
were adjusted based on the signal vs. noise ratio for MTX at different values. The values 
producing highest signal and lowest amount of noise were chosen.  
 
Table 17. MS/MS conditions for the entrance into the MS/MS, and transition of precursor ion 
to fragment 1 for MTX, 7-OH-MTX and DAMPA.  
Parameter Value 
Entrance potential (EP) 7 V  
Focusing potential (FP) 400 V 
Declustering potential (DP) 20 V 
Collision energy (CE) 30 V 
Collision cell exit potential (CXP) 15 V 
Collision cell entry potential (CEP) 15 V 
 
Table 18. Mass transitions for MTX, 7-OH-MTX and DAMPA. 








MTX 455.33 308.10 175.00 134.00 
7-OH-MTX 471.20 324.10 191.10 148.20 
DAMPA 326.10 175.00   
 
The precursor ion of MTX and 7-OH-MTX was fragmented into three daughter ions. 




  3.7.3 Evaluation of the LC-MS/MS method 
 
Samples analyzed on LC-MS/MS were prepared and marked with µM instead of mg/ml. 
There were two reasons for this; µM is a more exact unit of measurement, as it presents the 
number of molecules in a solution. Also, in a clinical context, the µM unit is more frequently 
used than mg/ml, for denoting concentration in biological fluids.  
 
For establishment of linearity, MTX was prepared in in concentrations ranging from 0.0016 – 
51.2 µM and analyzed by LC-MS/MS. The solvent for MTX was methanol. 
 
Table 19. Concentrations of MTX and its corresponding analyte signal intensity (cps) peak 
area.  




0.1 18 500 
0.2 36 500 
0.4 70 700 
0.8 149 000 
1.6 289 000 
3.2 599 000 
6.4 1 140 000 
12.8 2 360 000 





Figure 30. Standard curve of 1 μl 0.0016-0.4 μM MTX.    
 
Figure 31. Standard curve of 1 μl 0.8-51.2 μM MTX. 
 
A sample of 0.0004 μM MTX was also injected, but it did not produce a detectable peak in 
the chromatogram. The lower limit of detection was therefore 0.0016 μM MTX, based on the 
samples analyzed. Above 12.8 μM MTX, the standard curve was no longer linear. Hence, the 
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LC-MS/MS method for MTX was linear in the range 0.0016-12.8 μM.  
 
To check whether the instrument provided various signals between injections from the same 
sample, some of the samples from Table 19 were analyzed three times each.  
 
Table 20. Investigation of LC-MS/MS instrument precision.  
Concentration 
(μM) 
Analyte peak area 
(injection 1) 
Analyte peak area 
(injection 2) 
Analyte peak area 
(injection 3) 
0.1 18 500 18 900 17 800 
0.2 36 500 33 500 36 400 
0.4 70 700 70 900 71 200 
0.8 149 000 146 000 Not analyzed1 
1.6 289 000 285 000 288 000 
3.6 599 000 552 000 610 000 
1The needle did not retract from the vial after perforating the septum, and the sample was omitted from the 
injection queue.   
 
There were minor variations between injections, and there could be several reasons for this. 
First, the instrument was relatively old. The API 2000 MS/MS model was from 1997, thereby 
lacking the most recent technology. Second, and perhaps more decisive, the instrument had 
been idle for two years without regularly maintenance. This could cause variation in the 
injection volume by the autosampler, or in the elution gradient by the gradient pump. 
Therefore, it is expected that the precision would be higher using an instrument that had 
undergone the required maintenance. Nevertheless, the addition of an internal standard (IS) to 
the samples could adjust for the various signal intensities. This is because the analyte and IS 
are affected the same way by the instrumental variations. The ratio between them would give 
a true estimate of the signal intensity of the analyte.  
 
The linearity of 7-OH-MTX was not established, since the LC-MS/MS method did not appear 
to respond well to this metabolite. In Figure 29, 1 μl 1.33 μM 7-OH-MTX was analyzed in 
mixture with 0.212 μM MTX and 0.212 μM DAMPA. 7-OH-MTX provided a much lower 
signal despite the higher concentration. In the HPLC-UV method, the signal of 7-OH-MTX 
was 80% of the signal produced by MTX. This suggested that the problem lied in the LC-
MS/MS method, leading to incomplete ionization of the mother ion to fragment 1. This might 
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be explained by the additional OH-group of the analyte, interfering with the ring structures 
due to intramolecular forces and altering the physicochemical properties of the metabolite. 
Nevertheless, in order to establish an approved method for the analyte, the MS/MS conditions 
would have to be optimized for 7-OH-MTX specifically.  
 
DAMPA appeared to respond well to the method, and a standard curve of DAMPA was 
prepared and analyzed on LC-MS/MS with following concentrations:  
 
Table 21. Concentrations of DAMPA and its corresponding analyte signal intensity (cps) 
peak area. 
Concentration (µM) Analyte peak area  
0.0096 1590 
0.039 5720 
0.154 20 700 
0.616 79 100 
2.463 279 000 
9.850 881 000 
39.40 2 520 000 





Figure 32. Standard curve of 1 μl 0.0096-0.616 μM DAMPA. 
 
 
Figure 33. Standard curve of 1 μl 2.463-157.6 μM DAMPA. 
 
The standard curve of DAMPA was only linear in the range 0.0096-0.616 μM (Figure 32), 
which was narrower compared to the linear range for MTX. One reason for this could be that 
the LC-MS/MS method was developed for MTX, in assumption that it would apply similarly 
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to the metabolite. Thus, some of the parameters in Table 17 could have been suboptimal for 
DAMPA. Another explanation could be day-to-day variations of LC-MS/MS instrument 
performance, or the fact that the instrument is relatively old, as discussed above. Again, an IS 
could adjust for the reducing signal intensity DAMPA and increase the linearity of the 
method.  
 
Despite the lack of internal standard for adjustment of precision and linearity, the LC-MS/MS 
method was more sensitive than the HPLC-UV method for MTX. MTX could be detected at 
0.0016 μM by LC-MS/MS, whereas the lower limit of detection of the HPLC-UV method 
was 0.069 μM. Also, the injection volume of LC-MS/MS was 1 μl, compared to the HPLC-
UV method that injected 10 μl. With this taken into account, the LC-MS/MS method was 431 
times more sensitive than the HPLC-UV method. It was also more selective, as it could 
identity and quantitate all three metabolites in a mixture. In the current HPLC-UV method, 
MTX and 7-OH-MTX could not be separated in the column, and another method had to be 
used for separation and detection of DAMPA. 
 
  3.8 Calculations 
 





· 100%   (Equation 3) 
 
Where R is extraction recovery, AA is peak area for the analyte, and AStd is peak area for the 
standard solution. The same equation was applied for calculation of percentage of analyte in 
the donor solution.  
 










Where S is standard deviation, x is the recovery for each sample, x-bar is the mean recovery 
and n is the number of samples.  
 





∗ 100%  (Equation 5) 
 
Where S is the standard deviation, and X-bar is the mean recovery of the samples.  
 
The standard curves were calculated by following equation:  
 
𝑌 = 𝑎𝑥 + 𝑏   (Equation 6)  
 
Where a and b are constant numbers, x is the concentration of analyte and Y is the instrument 
response.  
 
The coefficient of determination (R2) value was calculated to observe how closely the data 
points fitted the trendline from the standard curves. The closer the R2 value was to 1, the 
closer the data points fitted the model. 
 
𝑅2 = 1 −
𝑆𝑆 𝑟𝑒𝑔𝑟𝑒𝑠𝑠𝑖𝑜𝑛
𝑆𝑆 𝑡𝑜𝑡𝑎𝑙
 (Equation 7) 
 
Where SS regression is the sum of squares due to regression, and SS total is the total sum of 






4  Results and discussion 
 
  4.1 Extraction of MTX as a cation through NPOE 
 
The extraction of MTX as a protonated base (cation) was a natural place to start, considering 
that most studies on EME are done on basic compounds, and successful SLMs and ionic 
carriers are established. In the initial experiments, MTX was attempted to be extracted 
through an SLM consisting of the widely used organic solvent, NPOE. Based on information 
from other users of EME, a supplied power of 100 V for 15 minutes was common for the 
extraction through NPOE. The agitation rate was set to 750 RPM, based on literature on EME 
suggesting that agitation rates between 500 and 1000 RPM are optimal (61).   
  
In experiment 1, both the donor and acceptor solution consisted of 50 mM HCl with a pH of 
1.3. The low pH value was chosen based on the pKa value of the basic nitrogen atom on 
MTX, which is 2.8. The Chemicalize database simulation estimates that 96% of MTX 
molecules are protonated at pH 1.3 (28).  
 
Table 23. Experiment 1. Result from extraction of 8 µg/ml MTX through NPOE.  












NPOE  50 mM HCl  
pH 1.3 
50 mM HCl 
pH 1.3 
100  15  750  0.0  
 
MTX was not detected in the acceptor solution. It is well known that the extraction of highly 
polar analytes (logP < 0) is particularly difficult with EME (23). MTX has multiple oxygen 
and nitrogen atoms that contribute to its polarity, and Chemicalize predicts that the molecule 
has a log D value of -0.64 at pH 1.3 (28). The amount of MTX left in the donor solution after 
extraction was 100%, suggesting no partition into the organic solvent despite applying 100 V 
to facilitate electrokinetic migration. The electrical current was very low during the 




  4.1.1 Extraction through NPOE including the ionic carrier DEHP 
 
The addition of the ionic carrier DEHP in NPOE has shown to be successful for extraction of 
moderately polar analytes with a logP of 0-2 (23). Experiment 2 was therefore carried out 
with 10% or 20% DEHP added to NPOE as the SLM, in hopes that it would yield higher 
transport of MTX into the acceptor solution.  
 
The donor solution consisted of a 20 mM KH2PO4 solution with a pH of 2.6. A more acidic 
solution could lead to loss of the negatively charged phosphate groups on DEHP, due to its 
pKa value of 1.94 (23). A higher pH could have kept the MTX molecules from being 
sufficiently protonated in the donor solution. Chemicalize predicted that 56% of the MTX 
molecules carry a positive charge at pH 2.6 (28). In theory, the protonated fraction would be 
extracted into the acceptor solution, followed by a new established equilibrium in the donor 
solution, which would ensure a continuous transfer of protonated MTX molecules. 
 
The acceptor solution consisted of a 50 mM HCl solution with a pH of 1.3. The low pH value 
was chosen to account for the possibility of electrolysis. DEHP has the tendency to increase 
current in the system, which will make the system more prone to electrolysis and elevated pH 
at the negatively charged cathode (33). 
 
Table 24. Constant parameters for experiment 2-4.  
Parameter Description 
Donor solution 20 mM KH2PO4 pH 2.6. 
Acceptor solution 50 mM HCl pH 1.3 
Time 15 minutes 










Table 25. Results from extraction of 8 µg/ml MTX through NPOE + DEHP 
Experiment SLM Voltage (V) Recovery acceptor 
solution (%)1 
2A NPOE + 
10% DEHP 
50  0.2 ± 0.1 
2B NPOE + 
10% DEHP 
100  0.4 ± 0.4 
2C NPOE + 
20% DEHP 
50  1.2 ± 0.9 
1All experiments are based on two parallels, where the deviation represents the difference between the mean 
value and the highest/lowest value. 
 
The recoveries of MTX were very poor in these experiments (Table 25). The amount of MTX 
in the acceptor solution was close to 0%. However, it appeared as if a great amount of the 
molecules had been removed from the donor solution, unlike the extraction through pure 
NPOE. In experiment 2B, 56.1 % of the added MTX was left in the donor vial, and 0.4% 
existed in the acceptor vial after extraction. The rest (43.5%) was not detected.  
 
The possibility of degradation of MTX due to high voltage was considered unlikely. In 
experiment 1, 100% of MTX was detected in the donor vial, despite using 100 V. Chemical 
degradation or precipitation of MTX due to the low pH neither appeared to be the case, as the 
analyte remained stable in the donor solution with a pH of 1.3 in experiment 1. Most likely, 
there was transport of the analyte into the SLM, or to the interfaces between the SLM and the 
aqueous solutions. This suggested that MTX had an affinity to DEHP, where the positively 
charged MTX molecules were attracted to the negatively charged phosphate groups on DEHP.  
 
To investigate whether MTX was transported into the SLM, or existed in the aqueous 
solutions/SLM interfaces, experiment 2C was performed again, with the agitator running for 5 
additional minutes after turning off the voltage. If MTX interacted with DEHP in the 
interfaces, it was hypothesized that the molecules would diffuse back into the donor/acceptor 
solutions once they were no longer influenced by the electrical field. The results showed a 
recovery of 46.3% in the donor solution, and 3.1% in the acceptor solution. The additional 2% 
recovery of MTX in the acceptor solution may be due to release of MTX ions at the acceptor 
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solution/SLM interface. However, it may also be a coincidence due to variability in the 
technical or conductive properties of the vials, which will be discussed in section 4.5.1. 
Nevertheless, a great amount of MTX was still not detected in neither the donor nor acceptor 
solution.   
 
To check if the MTX molecules were trapped inside the SLM, the PP-membrane was 
removed from the union and placed inside another vial after extraction. To this vial, 250 µl 10 
mM NaOH was added, in which MTX is soluble. The vial was shaken for 10 minutes and its 
content analyzed on HPLC. 1.2% of MTX was detected, indicating that some of the analyte 
existed in the SLM, but the rest may not have been released through stirring alone.  
 
The amount of DEHP in NPOE was then reduced to 5%, 2.5%, 0.5% and 0.125% to see if the 
combined recoveries in the donor and acceptor solutions increased. The theory proposed that 
a reduced percentage of DEHP in the SLM would lower its ability to bind MTX, and more 
MTX molecules would exist in the aqueous solutions. The constant parameters for the 
following experiments are listed in Table 24.  
 
Table 26. Results from extraction of 8 µg/ml MTX through NPOE including decreasing 
amounts of DEHP. 




3A NPOE + 5.0% 
DEHP 
100  54.5% 1.6 % 
3B NPOE + 2.5% 
DEHP 
100  51.9 % 0.5% 
3C NPOE + 0.5% 
DEHP 
100  50.5 % 0.6% 
3D NPOE + 0.125% 
DEHP 
100  75.4 % 0% 
 
The results show that with a concentration of 0.5-5% DEHP in the SLM, more than 40% of 
the MTX molecules were still not detected. A reason for this is that 0.5% DEHP may still be 
sufficient to interact with MTX and trap the analyte in the membrane. However, at 0.125% 
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DEHP, 75.4% of MTX was detected in the donor solution. This demonstrates that with a 
decreasing amount of carrier, an increased fraction of the MTX molecules is left in the donor 
solution. This also supports the theory that MTX has a strong affinity to DEHP.  
 
Another theory on why such an extensive amount of the MTX molecules was undetectable 
with a concentration of DEHP from 0.5-20%, is that the positively charged molecules had in 
fact been extracted into the acceptor solution, but had been adsorbed onto the negatively 
charged acceptor vial wall during extraction. Due to the low solubility of MTX in acidic 
conditions, it could be that the molecules were not released from the wall of the acceptor vial 
after the extraction. To investigate this theory, the acceptor solution was removed from the 
acceptor vial after extraction, followed by addition of 250 µl phosphate buffer with pH 7.4, in 
which MTX is soluble, and which should be able to release MTX from the inside of the vials. 
The vial was shaken for 10 minutes and the contents analyzed on HPLC. No MTX was 
detected in the phosphate buffer from the acceptor vial, demonstrating that strong interaction 
between MTX and the negatively charged vials did not occur during EME.  
 
In conclusion, in its cationic state MTX most probably had a strong affinity to DEHP and was 
immobilized in the SLM. Once the analyte formed ionic bonds with DEHP and diffused into 
the SLM, it may have lost overall positive charge and was not readily influenced by the 
electrical field. The reason why the analyte was not released into the acceptor solution could 
be elevated pH in the acceptor solution during extraction due to electrolysis (equation 2), 
and/or the formation of an electrical double layer at the acceptor solution/SLM interface. This 
may have resulted in a lack of protons in the interface, with reduced protonation of DEHP and 
consequent lack of the ability to release MTX into the acceptor solution. For further 
investigation, the pH in the acceptor solution could have been measured before and after 
extraction to draw clearer conclusions. Another reason why MTX was not released to the 
acceptor solution could be that MTX has a low solubility at low pH values, and its affinity to 
the carrier may have been greater than to the acidic aqueous acceptor solution. 
 
  4.2 Extraction of MTX through 2-Nitrophenyl pentyl ether + 
DEHP 
 
2-Nitrophenyl pentyl ether (NPPE) is another organic solvent used as SLM in EME, and it 
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differs from NPOE by containing a pentyl hydrocarbon chain instead of octyl hydrocarbon 
chain.  
 
Figure 34. Chemical structure of NPPE. Downloaded from (62). 
 
Due to the shorter hydrocarbon chain, NPPE is less hydrophobic than NPOE. This might 
favor partition of MTX into the SLM and release to the acceptor solution.  
 
Three NPPE experiments were performed, with constant extraction parameters listed in Table 
24. The varying parameters in the following experiments were % DEHP in NPPE and voltage.  
 
Table 27. Results from extraction of 5 µg/ml MTX through NPPE including DEHP. 
Experiment DEHP in NPPE 
(%) 




4A 20  50 15.0 ± 7.1 7.1 ± 0.4 
4B 20  100 5.8 4.6 ± 0.7 
4C 10 100 - 3.3 ± 0.4 
1All experiments are based on two parallels, where the deviation represents the difference between the mean 
value and the highest/lowest value. In experiment 4B, the chromatogram of one donor solution contained peaks 
that could not be separated and quantified by HPLC. In experiment 4C, this applied for the chromatogram of 
both donor solutions.  
 
The extraction recoveries were higher when using NPPE compared to NPOE, with 7.1% as 
the best result. The enhanced recoveries were most likely due to the reduced hydrophobicity 
of NPPE, which allowed MTX to partition into the SLM more easily. The amount of MTX 
removed from the donor solutions was also larger than in the experiments with NPOE, 




The extraction current was observed during extraction of all experiments. In experiment 4A, 
the current was approximately 20 µA for each sample. In experiment 4B and 4C, the current 
was 100 and 70 µA, respectively. This confirmed that an increasing amount of DEHP, and 
higher voltage, increased the current in the system. For experiment 4B-4C, 20% DEHP in the 
SLM seemed to be favorable compared to 10% DEHP, despite the higher current. However, a 
high concentration of DEHP (20%) combined with 50 V resulted in the highest recovery.  
 
MTX has a retention time of 2.9 minutes on HPLC. In the experiments with NPPE, another 
peak appeared in the chromatogram at 2.8 minutes (Figure 35). This peak was visible in all 
three experiments. However, it only appeared in the donor solutions.  
 
 
Figure 35. Chromatogram of a donor solution from experiment 4A. 
 
At first, it was suggested that this peak could represent DEHP that had leaked into the donor 
solution. However, after adding 5 µl DEHP to a blank 20 mM KH2PO4 solution, no peaks 
appeared on the chromatogram after running the sample on HPLC.  
 
The peak did not represent NPPE, as this compound has a retention time of 6.5 (Figure 35). 
The identity of the peak was confirmed when running a blank 20 mM KH2PO4 solution spiked 
with 5 µl NPPE, providing a strong signal at 6.5 minutes. The same peak also appeared with 
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the same retention time in the chromatograms from the samples extracted through NPOE. 
This did not come as a surprise, as the two organic solvents are highly similar in terms of 
molecular structure.  
 
In two of the experiments (4B-C), the two peaks were not resolved, and the area under the 
curve was not possible to calculate for each peak. It was hypothesized that the peak at 2.8 
minutes represented a derivative of MTX, produced by a chemical degradation during EME. 
Alternatively, it could represent MTX complexed to DEHP, leaked from the SLM. However, 
the UV spectrum of the peak at 2.8 minutes showed no similarities to the UV spectrum of 
MTX, and both theories therefore seemed unlikely. It remains unknown what compound the 
additional peak represented. 
  4.2.1 Final thoughts on the extraction of MTX as a cation 
 
When extracting MTX as a cation, the positive charge is located at the end of the pteridine 
ring residue (Table 1). Generally, a charged analyte has a relatively high water solubility, and 
a relatively poor solubility in organic solvents (14). The other end of the MTX molecule 
contains two carboxylic acids, which will also contribute to its polarity. Even though the 
carboxylic acids are neutrally charged in acidic solutions, the oxygen atoms are 
electronegative and attract bonding pair of electrons, increasing the polarity of the covalent 
bonds and the molecule (63). Hence, both ends of the MTX molecule can possibly contribute 
to the polarity of MTX and make its partition into the SLM more demanding. However, when 
extracting MTX as a deprotonated acid, the pteridine ring residue is neutrally charged and 
contributes less to the polarity, whereas the deprotonated carboxylic acids are highly polar. 
Having a relatively non-polar part of the molecule might favor the partition into the SLM, and 
in the remaining sections, EME of MTX as a deprotonated acid will be discussed.  
 
  4.3 Extraction of MTX as an anion through aliphatic alcohols 
 
Aliphatic alcohols have proved to be efficient SLMs for the extraction of acidic substances. 
Long-chain alcohols with strong proton acceptor properties, especially 1-octanol, have shown 
to yield successful extractions (64). 
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  4.3.1 Extraction of MTX through 1-octanol 
 
In the initial experiments, MTX was extracted through 1-octanol. The pH in the donor 
solution was 7.4, to mimic the physiological pH of plasma, and Chemicalize simulates that 
almost 100% of the MTX molecules carry two negative charges at this pH (28). The pH in the 
acceptor solution was set to 12 by using 10 mM NaOH. The reason why the pH was set 
significantly higher in the acceptor solution than in the donor solution, was to counter for the 
possible reduction in pH due to electrolysis, and the formation of an electrical double layer.  
 
Table 28. Constant parameters for experiment 5-8. 
Parameter Description 
Donor solution 40 mM phosphate buffer, pH 7.4 
Acceptor solution 10 mM NaOH, pH 12 
Time 15 minutes 
Agitation 750 RPM 
 
Table 29. Results from extraction of 5 µg/ml MTX through 1-octanol at 50 V and 100 V 
Experiment SLM  
 






5A 1-octanol 50 90.6 0.5 
5B 1-octanol 100 45.4 3.3 
 
Table 29 shows very poor recovery of MTX in the acceptor solutions. At 50 V, the extraction 
current was low during the whole extraction (8 µA). This indicates low flux of ions across the 
membrane. The most likely explanation is that MTX is too polar to partition into the SLM at 
this voltage. The Chemicalize database simulation estimates that MTX has a log D value of -
6.56 at pH 7.4, which indicates that the analyte has very little affinity to the organic phase 
(28).  
 
At 100 V, the extraction current was significantly higher (150 µA). The recovery in the donor 
solution was 45.5% (Table 29), suggesting that a great amount of MTX molecules partitioned 
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into the SLM at this voltage. However, only 3.3% was released into the acceptor solution. The 
reason why over 50% of MTX molecules were absent from the aqueous solutions is unknown, 
as one would assume that the analyte had a higher affinity to aqueous conditions than the 
organic solvent. One possible explanation is that once the analyte partitioned into the SLM at 
100 V, intermolecular forces between MTX and 1-octanol hampered the release of MTX into 
the acceptor solution. 1-octanol has an OH-group capable of hydrogen bond interaction with 
the deprotonated carboxylic acids on MTX. A more vigorous shaking (>750 RPM) could have 
been attempted to break the possible interactions between MTX and 1-octanol. However, this 
would also contribute to higher current in the system, and the current was already high (150 
µA). As previously mentioned in section 2.2.3,  a current exceeding 50 µA is generally not 
recommended in EME due to the possibility of adverse electrolysis (33). 
 
Therefore, a more likely explanation for the poor release of MTX into the acceptor solution is 
that the high current (150 µA) led to electrolysis and reduced pH in the acceptor solution. In 
addition, if positive charge accumulated at the SLM/acceptor interface due to the formation of 
an electrical double layer, this might have led to loss of negative charge from MTX once it 
reaches the acceptor side of the SLM. In this way, MTX would no longer be influenced by the 
electrical field, and it would accumulate in the SLM.  
 
  4.3.2 Extraction of MTX through 1-octanol with aliquat 336 as ionic 
carrier 
   
Aliquat 336 is an ionic carrier used to facilitate extraction of anionic substances. Unlike 
DEHP, which is a pH dependent carrier of cationic substances, aliquat 336 is characterized by 
a permanent positive charge. This allows a more flexible choice of pH in the donor and 
acceptor solutions when extracting MTX as an anion.  
 
5 µg/ml MTX was extracted through 1-octanol containing different amounts of aliquat 336 
(0.5%, 1% and 2%). The extraction voltage was 5 or 10 V. A low voltage was chosen because 
the extraction current increased significantly above 10 V, leading to an unstable system. The 
pH was measured in the donor and acceptor solutions before and after extraction, to observe 
the effects of electrolysis. The current was recorded to investigate the relationship between 
extraction current, voltage, amount of aliquat 336 in the SLM, pH changes and recovery. The 
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constant parameters listed in table 28 are valid for the experiments described below.  
 
Table 30. Results from extraction of 5 µg/ml MTX through 1-octanol including aliquat 336. 
Exp % Aliquat 







pH change in 
donor solution 
(pH units)1 
pH change in 
acceptor solution 
(pH units)1 
6A 2  5 35.2 ± 0.5 +0.25 ± 0.02 -3.16 ± 0.07 
6B 1  5 43.2 ± 1.2 +0.16 ± 0.03 -1.59 ± 0.20 
6C 1  10 29.3 ± 5.3 +0.94 ± 0.16 -5.87 ± 0.20 
6D 0.5  5 33.3 ± 4.1 +0.13 ± 0.01 -1.12 ± 0.13 
6E 0.5  10  32.8 ± 0.7 +0.28 ± 0.02 -3.81 ± 0.59 
1All experiments are based on two parallels, where the deviation represents the difference between the mean 
value and the highest/lowest value.  
 
 
Figure 36. Extraction current for experiments 6A-6E. Each trace is from one EME extraction 
of two samples, representing the sum of the extraction currents of both samples.  
 
The lowest recovery (29.3%) was obtained from experiment 6C. As illustrated in Figure 36, 
the extraction current greatly increased after approximately 1 minute, and increased 
throughout the extraction. The pH in the acceptor solution dropped almost 6 units, resulting in 


























10 V, the concentration of aliquat 336 (1%) in the SLM was too high, and this combination 
apparently generated an excessive current. The reduced pH in the acceptor solution due to 
electrolysis might led to a reduced affinity of the MTX molecules to the acceptor solution, 
and an elevated affinity to the positively charged carrier. A formation of an electrical double 
layer at the acceptor solution/SLM interface might have led to temporary loss of negative 
charge of the carboxylic acids on MTX, with resultant back-extraction towards the donor 
solution. As the MTX molecules reaches the SLM/donor solution interface, the basic 
electrical double layer might have worked in favor of deprotonation MTX, and re-interaction 
with aliquat 336.     
 
In experiment 6A, 6D and 6E, the mean recoveries ranged from 32.8% to 35.2%. Hence, the 
different combinations of the amount of carrier in the SLM and the applied voltage in these 
experiments yielded almost the same recoveries of MTX. However, experiment 6D stands out 
compared to experiment 6A and 6E because electrolysis and pH changes occurred to a 
minimal degree. Despite the relatively stable system conditions, the combination of low 
voltage (5 V) and low concentration of aliquat 336 (0.5%), might have prevented effective 
partition of MTX into the SLM and liberation into the acceptor solution. A longer extraction 
duration might have facilitated higher recoveries, given that the extraction current remained 
stable over time. A more vigorous shaking (>750 RPM) also might have made faster 
extraction possible, but this could in turn have generated excessive current.  
 
Experiment 6B yielded the highest recovery (43.2%). It seemed like the combination of 1% 
aliquat 336 in the SLM and 5 V was beneficial for EME through 1-octanol. The total current 
for both samples was approximately 150 µA. Ideally, it should be < 50 µA for one sample, 
but the level of electrolysis was not dramatic. The pH drop in the acceptor solution was 1.59 
units. A drawback with this experiment is that the current curve shows a slight increase over 
time, suggesting extraction instability. Ideally, the curve should initially descend and then 
stabilize, like the current curve illustrated in Figure 24, or the current curve for experiment 
6A. However, in experiment 6A, the overall current was too high.  
 
The experiments show correlation between extraction current and pH changes. As the total 
current for two samples exceeds 200 µA, the pH reduction in the acceptor solution becomes 
higher than 3 units, and extraction recovery decreases. The reason why the pH dropped more 
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dramatically in the acceptor solution compared to the slight increase in the donor solution, is 
likely to be caused by the donor solution consisting of a 40 mM phosphate buffer. A higher 
molarity would probably have generated more background ions, and thereby a higher flux of 
ions over the membrane. A lower concentration could have reduced its buffer capacity and 
ability to prevent pH changes due to electrolysis. 
 
  4.3.3 Extraction of MTX through 1-nonanol and 1-nonanol/1-octanol 
added aliquat 336 
 
The chemical structure of 1-nonanol is one carbon unit longer than 1-octanol, making it more 
hydrophobic and viscous. It was therefore introduced as an SLM due to its potential to 
counteract high current and electrolysis in EME, while keeping the properties that are suitable 
for solvation of deprotonated analytes.  
 
Since 1% aliquat 336 in the SLM appeared to facilitate the highest recoveries in the extraction 
through 1-octanol, the same concentration of carrier was applied to the experiments with 1-
nonanol, and 1-octanol/1-nonanol (v/v) mixture. The parameters listed in Table 28 are 
constant in the following experiments (7A-7E). 
 
Table 31. Results from extraction of 5 µg/ml MTX through 1-nonanol and 1-nonanol/1-
octanol including 1 % aliquat 336. 





pH change in the 
donor solution 
(pH units)1 
pH change in the 
acceptor solution 
(pH units)1 








20 21.5 ± 0.1 +0.52 ± 0.02 -4.80 ± 0.04 
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7D 1-octanol/  
1-nonanol 
(2:1)  




20 17.8 ± 1.3 +0.48 ± 0.03 -4.56 ± 0.04 
1All experiments are based on two parallels, where the deviation represents the difference between the mean 
value and the highest/lowest value. 
 
The increased hydrophobicity and viscosity of 1-nonanol made the partition of MTX into the 
SLM more demanding. The voltage therefore had to be increased, to be able to force the 
analyte through the membrane. At 20 V, the extraction current in experiment 1 was around 60 
µA for two samples (Figure 37).  
 
 
Figure 37. Extraction current for experiment 7A. The trace is from one EME extraction of 
two samples, representing the sum of the extraction currents of both samples. 
 
A recovery of 10.7% was achieved in experiment 7A. It is likely that a higher voltage, such as 
30 or 40 V, could have facilitated higher recoveries. Based on the experiments 6A-E, it is 




















relatively low current, and that the system could have handled a higher voltage. A prolonged 
extraction duration and more forceful agitation could also have contributed to increase the 
recovery in the acceptor solution.  
 
When 1-octanol was added to 1-nonanol in the SLM, the extraction current greatly increased. 
Current curves were not recorded during these experiments, because experiment 7C+7E and 
7B+7D were performed simultaneously, and the curves would be based on a mixture of the 
conditions in these two experiments. However, the pH changes in Table 31 strongly suggest 
that electrolysis occurred. Apparently, 20 V was too powerful for the system, even with 50% 
1-nonanol in the SLM, and the pH dropped more than 4 units in the acceptor solution.  
 
The highest recoveries were achieved in experiment 7B and 7D (27.6 and 31.2%, 
respectively). In both experiments, 10 V was applied, and the pH was not dramatically altered 
(around 2 units). However, compared to the experiments with only 1-octanol added aliquat 
336, recoveries in the acceptor solution generally decreased when introducing 1-nonanol to 
the SLM.  
 
To achieve higher extraction recoveries, different combinations of 1-octanol/1-nonanol ratio, 
amount of ionic carrier and extraction voltage would have to be investigated further. Also, the 
other parameters (e.g., time and agitation) would have to be adjusted to optimize the 
extraction of MTX through aliphatic alcohols added aliquat 336. Still, it is unlikely that 
adjustment of these parameters would lead to the desired level of recovery in the acceptor 
vial. In this study, the aim is to reach higher than 70% recovery of MTX in the acceptor 
solution, as ≈ 70% is the level of recovery of MTX obtained by protein precipitation in 
Rikshospitalet in Oslo (section 1.4).   
 
  4.4 Extraction of MTX as an anion through NPOE with aliquat 
336 as an ionic carrier 
 
Since the ionic carrier aliquat 336 seemed to be the key to achieve higher extraction 
recoveries in the experiments with aliphatic alcohols, it was added to several different oils, 
including NPOE. Even though NPOE has mostly been used in extraction of cationic analytes, 
it holds qualities that represents a successful SLM, such as low solubility in aqueous solutions 
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and relatively low viscosity (33).  
 
A combination of different amounts of aliquat 336 in the SLM (1% and 0.5%), and different 
voltages (5, 10 and 20 V) were applied to get an insight into favorable conditions for EME of 
MTX through NPOE added aliquat 336. The pH was measured before and after extraction, 
but only the reduction of pH in the acceptor solution is listed in Table 32. This is because the 
pH was relatively stable in the donor solution due to the presence of the phosphate buffer. The 
extraction parameters listed in Table 28 were applied to the following experiments.  
 
Table 32. Results from extraction of 5 µg/ml MTX through NPOE added aliquat 336.  
Exp % aliquat 









pH change in the 
acceptor solution 
(pH units)1 
8A 1 5 18.1% ± 3.5 30.6 % ± 2.9 -1.4 ± 0.1 
8B 1 10 8.5% ± 0.9 
 
30.3% ± 4.7 -3.2 ± 0.4 
8C 1 20 7.3% ± 0.1 
 
23.7 % ± 2.2 
 
-4.5 ± 0.0 
8D 0.5 5 89.3% ± 4 5.0 % ± 1.6 -0.7 ± 0.1 
8E 0.5 10 100.3% ± 2.8 0.3 % ± 0.3 -0.8 ± 0.1 
8F 0.5 20 43.7% 
 
32.7% -1.22 
1All experiments except from 8F are based on two parallels, where the deviation represents the difference 
between the mean value and the highest/lowest value. 
 
The results show that a low concentration of carrier (0.5%) combined with low voltages (5 
and 10 V) was disadvantageous for EME, and most of the MTX was left in the donor solution 
(Table 32). However, a higher concentration of carrier (1%) combined with low voltages (5 
and 10 V) seemed to dramatically increase the recoveries. The best parameters for these 
experiments appeared to be the combination of low concentration of carrier (0.5%) and high 
voltage (20 V). Experiment 8E showed peculiar results, because it was expected that the 
donor/acceptor recoveries would be between the values of experiment 8D and 8F. Instead, the 
recovery in the acceptor solution was 0.3%. The reason is unclear, but might be poor 
conductive properties of one or two of the vials used during extraction, which will be further 
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discussed in section 4.5.1.  
 
Apparently, there is a correlation between the proportion of aliquat 336 in the SLM and 
voltage, and the combination must be fine-tuned to obtain the best results. The reason is most 
likely that both parameters increase the current in the system. The voltage as well as the 
proportion of aliquat 336 must be high enough to facilitate electrokinetic migration and 
partition into the SLM, but not so high that the current exceeds the level where adverse 
electrolytic reactions affects the extraction, like what occurred in experiment 8C (Table 32).  
 
Compared to the experiments 6B-E with 1-octanol, where the same parameters were applied, 
NPOE was generally a less efficient SLM than 1-octanol. This did not come as a surprise, 
since long-chained alcohols are more known for successful extractions of anionic analytes 
(33).   
 
  4.5 Extraction of MTX as an anion through peppermint oil 
with aliquat 336 as an ionic carrier 
 
The extraction of MTX through peppermint oil was attempted at a relatively early stage, in a 
period of experimenting with different SLMs. Peppermint oil is not a frequently used SLM for 
EME, but has shown promising results in a study of EME of non-polar, basic analytes (65). 
Even though the analytes in the study by Pedersen-Bjergaard and Rasmusen had 
physicochemical properties highly differing from MTX, peppermint oil was considered worth 
trying. The product was easily obtained from a local pharmacy, it was cheap and represented a 
“green-chemistry” alternative to other solvents. Although not suitable as an ingredient in a 
routine lab for drug analyses due to incomplete characterization, experiments using 
peppermint oil could give valuable information on how to extract negatively charged 
molecules by EME.  
 
At first, MTX was extracted through pure peppermint oil, and peppermint oil with 1% aliquat 
336. The experiments involved 40 mM phosphate buffer pH 7.4 as donor solution and 10 mM 





Table 33. Initial results from extraction of 8 µg/ml MTX through peppermint oil. 









9A Peppermint oil 100 15 750  6.9% ± 0.8 
9B Peppermint oil + 
1% aliquat 336 
10 20 750 61.4% ± 2.2 
1Experiments are based on two parallels, where the deviation represents the difference between the mean value 
and the highest/lowest value. 
 
The extraction through pure peppermint oil yielded poor recoveries. The extraction current 
was approximately 7 µA, indicating a stable, but low flux of ions across the SLM. However, 
when 1% aliquat 336 was added to the SLM, the recovery was higher than those obtained 




Figure 38.  Extraction current for experiment 9B. The trace is from one EME extraction of 






















The extraction current for experiment 9B was 100 µA distributed to 2 samples, resulting in an 
individual current of approximately 50 µA per sample (Figure 38). 
 
Based on the promising initial results using peppermint oil, further conditions were tested. 
However, during the experimentation with EME of MTX through peppermint oil added 
aliquat 336, it was discovered that the recoveries often varied highly among parallels. For 
example, 3 samples of 5 µg/ml MTX were extracted through peppermint oil added 2% aliquat 
336 at 5 V in 15 minutes. The recoveries were 22.9%, 19.9% and 8.0%. Results like these 
were obtained regularly, and they were difficult to draw conclusions from. Given that only 
one of the three samples were extracted, 8% recovery could have been the result, whereas the 
extraction conditions were in fact optimized for over 20% recovery. The problem with 
varying results applied to other SLMs (NPOE, 1-octanol, 1-nonanol) as well. The relative 
standard deviation was often unexpectedly high, even though the samples were prepared 
similarly and extracted under the same conditions.  
 
  4.5.1 Investigation of intra-experimental variation with peppermint oil as 
SLM. 
 
The variation in the extractions could be due to the operational technique, various supply of 
voltage from the electrodes, poor contact between the electrodes and the vials, or differences 
in vial performance. To get a better impression of exactly how much the recoveries varied 
among parallels, 8 samples were extracted simultaneously under following conditions:  
 
Table 34. Constant parameters for experiment 10-12.   
Parameter Description 
Time 20 minutes 
Agitation  750 RPM 
Voltage 10 V 
SLM Peppermint oil + 1 % aliquat 336  
Donor solution 40 mM phosphate buffer 





Table 35. Experiment 10. Results from the investigation of the RSD. 














RSD (%) 16.8 
 
The results varied from 45.6% to 79.6%. The extraction of multiple parallels was therefore 
crucial to see the trend in recovery, given that the causes for the large RSD shown in Table 35 
was not yet revealed.  
 
Different explanations on why the results varied by such a degree were considered. The 
reason could have been practical; the EME procedure involves multiple operational steps, 
with the potential of operational variance. Examples could be different amounts of SLM 
pipetted onto the PP membrane due to the viscosity of the SLM, or the PP-membranes 
positioned differently inside the unions. If these were the main reasons for the large RSD, it 
would have been difficult to correct, since the procedure already was performed with utmost 
care.  
 
Another possible explanation was variable or poor contact between electrodes and the 
conducting vials, or that the respective electrodes supplied different amounts of voltage. This 
could have facilitated a high degree of electrokinetic migration in some samples, and poor 
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transport in others. However, the multimeter was used to measure the performance of each 
pair of electrodes by adding a conducting object across each pair of electrodes, measuring the 
electrical current. The current was identical for all ten pairs of electrodes, demonstrating that 
the cause of variation was not due to the electrodes.  
 
A third reason for the considerably large RSD, was that the conductive vials lost their 
performance over time. This could have been due to a coating of unwashed substances inside 
or outside of the vials, altering their conductive properties. Even though the vials were 
washed with ethanol 3-4 times, followed by a 3-4 times wash with Milli-Q water, some of the 
more hydrophobic substances leaked from the SLM could have remained inside the vials. It 
could also be that the vials were produced with slight differences, and that some were 
technically more suited for reproducible results. For example, the upper vial surface that 
connects to the PP membrane could vary in diameter, possibly securing some samples better 
than others and prevented leaking.  
 
To investigate whether the elevated RSD was due to loss of vial performance over time, the 
experiment in Table 35 was performed again, but with new and unused vials.  
 
Table 36. Experiment 11. Results from the investigation of the RSD by using new vials.  














RSD (%) 2.7 
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Here, the RSD was only 2.7%, compared to 16.8% with the older vials that had been 
frequently used. With this new insight in mind, multiple experiments were performed again 
with new vials to obtain more reliable results.  
 
  4.5.2 Extraction of MTX without the application of voltage 
 
To confirm the advantage of the power supply in EME, 5 μg/ml MTX was extracted through 
an SLM consisting of peppermint oil + 1% Aliquat 336 in 20, 30, 40, 50, 60 and 90 minutes, 
but without applying voltage. The agitation was 750 RPM.  
 
Table 37. Experiment 12. Results from extraction of 5 µg/ml MTX without the application of 
voltage. 






1 20  76.2 18.0  
2 30  78.2  21.3  
3 40  76.4  25.5  
4 50  75.4  22.0  
5 60 63.6  33.9  





Figure 39. Recovery (%) of donor and acceptor solution plotted against time from experiment 
12.  
 
The results in Table 37 shows that MTX could, to a lesser degree, be transported through the 
SLM without being influenced by an electrical field. This means that the migration of the 
analyte was based on passive diffusion across the SLM. Most likely, the ionized MTX 
molecules from the donor solution formed ionic bonds with the positively charged carrier and 
diffused into the SLM. Since MTX is polar, and more soluble in basic conditions, it was 
liberated into the more basic acceptor solution.  
 
Above 60 minutes, the recovery in the acceptor vial presumably reached its maximum. It is 
unclear why the recovery decreased in the acceptor solution at 90 minutes. An interesting 
observation from Table 37 was that almost all of the originally added MTX molecules were 
detected either in the donor or the acceptor solution at 20-60 minutes. This was unexpected, as 
most extractions including an ionic carrier resulted in some loss of the analyte to the SLM. 
For sample 3 and 5, the total recovery even slightly exceeded 100%, likely to be explained by 
the precision of the HPLC-UV method. In sample 6, however, the total recovery was only 
65%. This sample was shaken for 30 minutes after sample 5, but there is no explanation to 





























In conclusion, the highest recovery without applying voltage was obtained after 60 minutes, 
with 33.9% MTX detected in the acceptor solution. This demonstrates the importance of the 
power supply in order to get high recoveries and faster extractions with EME.  
 
  4.5.3 Investigation of optimal parameters in extraction of MTX through 
peppermint oil with 1 % aliquat 336  
 
New vials were used to observe the relationship between extraction time, voltage, agitation, 
and recovery in the extraction of MTX through peppermint oil + 1% aliquat 336. At first, 8 
samples of 5 µg/ml MTX were extracted at 10 V. Samples were removed at different times, to 
observe the time where the highest recoveries were achieved. 
 
Table 38. Constant parameters for experiment 13-17. 
Parameter Description 
Donor solution 40 mM phosphate buffer, pH 7.4 
Acceptor solution 10 mM NaOH, pH 12 
SLM Peppermint oil + 1% aliquat 336 
 











Sample Extraction time (min) Recovery acceptor solution (%) 
1 10 51.4  
2 12  58.4  
3 14  59.9  
4 16  67.7  
5 18 68.1  
6 20 60.7  
7 22 71.3  




Figure 40. Recovery plotted against time (experiment 13).  
 
The recovery increased with time, with sample 6 being an outlier. The trend clearly 
demonstrates that longer extraction times facilitated higher yields in experiment 13. To 
investigate at what point the recovery in the acceptor solution reached its threshold, more 
samples would have to be extracted for a longer time. During the investigation of the RSD of 
new vials in experiment 11, the pH in the donor and acceptor solutions was measured before 
and after extraction. After 20 minutes of extraction, the mean pH reduction in the acceptor 
solution was 1.4 units. The pH would most likely have dropped further with longer 
extractions, and based on the experiments with 1-octanol, a pH reduction larger than 
approximately 2 units appeared to be unfavorable for EME. However, the current curve for 
the eight samples extracted simultaneously in experiment 11 seemed to be stable for 20 
minutes (Figure 41), and it is reasonable to assume that the EME system could tolerate 































Figure 41. Extraction current for 8 samples extracted with new vials to investigate the RSD 
(experiment 11). The trace represents the sum of the extraction currents of all samples. 
Conditions for the experiment is given in Table 34.  
 
However, for EME to be a routine sample preparation technique, it is desirable with fast 
extractions. Extractions longer than 24 minutes are therefore not ideal. Considering this, 8 
new samples were extracted at 15 V instead of 10 V, to find if high recoveries in the acceptor 
solution could be obtained faster. Also, additional 8 samples were extracted at 10 V with 800 
RPM instead of 750 RPM, to find if stronger agitation could increase extraction. 
 





1 8 40.5  
2 10 48.4  
3 12  48.6  
4 14  60.4  
5 16  48.2  
























7 20 63.0  
8 22 59.1  
 
Table 41. Experiment 15. Results from extraction of 5 µg/ml MTX at 10 V and 800 RPM. 




1 8 44.5  
2 10 52.4  
3 12  61.0  
4 14  68.5  
5 16  72.3  
6 18 54.8  
7 20 59.2  
8 22 68.4  
 
 
Figure 42. Recovery plotted against time at two different voltages and agitation speeds 
(experiment 14 and 15).  
 
The results suggest that applying higher voltage (15 V) was not a favorable step for EME, in 


























solutions were generally less than in experiment 13. However, when increasing the agitation 
from 750 RPM to 800 RPM at 10 V, 72.3% recovery was achieved at 16 minutes, compared 
to 67.7% in experiment 13.  
 
Nevertheless, the current in experiment 14 and 15 kept increasing throughout the extraction, 
despite the removal of a sample every two minutes (Figure 43). This indicates instability and 
electrolysis, and might explain the overall poorer recoveries in the acceptor solutions. It is 
possible to see a direct correlation between the current and recovery based on the current 
curves. When looking at the red trace representing experiment 14 in Figure 43, the current 
significantly decreased after sample 5 was removed from the sample holder. Sample 5 
therefore had an excessive flux of ions across the membrane at 16 minutes (approximately 
700 - 200 = 500 μA). The recovery of sample 5 was 48.2 %, which was less than the samples 
removed before and after.  
 
The trace for experiment 13 indicated much more stable conditions. As expected, the total 
current generally decreased as samples were removed one by one from the sample holder.  
 
Figure 43. Extraction current for experiment 13-15. Each segment indicates removal of one 





















13: 10 V 750
RPM
Experiment
14: 15 V 750
RPM
Experiment




Based on the three experiments, the experiment with 10 V and 750 RPM seemed to be the 
most reliable in terms of extraction current and recovery. However, the extraction duration 
would have to be more than 20 minutes in order to yield above 70% recovery in the acceptor 
solution. Multiple samples could have been prepared for the extraction at 10 V and 800 RPM 
for 16 minutes. If the results were reproducible, and yielded approximately 73.6% recovery 
each time, this would be convenient in terms of faster extractions.  
 
More experiments could have been attempted to optimize extraction recoveries. For example, 
7, 8 or 9 V combined with 800 RPM might have facilitated faster extractions and combated 
electrolysis. Also 10 V could have been combined with an agitation between 750 and 800.  
 
  4.5.4 Extraction of 7-OH-MTX and DAMPA through peppermint oil 
with aliquat 336 as an ionic carrier 
 
Three samples of 5 µg/ml 7-OH-MTX were extracted for 20 minutes using the same 
parameters as in Table 38. Due to structural resemblance to MTX, it was expected that the 
metabolite would behave the same way, in terms of interacting with aliquat 336 and be 
transported across the SLM.  
 
Table 42. Experiment 16. Result from extraction of 5 µg/ml 7-OH-MTX. 









Peppermint oil + 
1% aliquat 336 
10 20 750 59.0 
1Experiment is based on three parallels, with an RSD of 5.3%. 
 
The recovery was approximately 10% lower than for MTX. This can be explained by the 
additional OH-group of the metabolite (Figure 14), which contributes to its increased polarity. 
Hence, 7-OH-MTX had less affinity to the hydrophobic SLM. In order to gain higher 
recovery of 7-OH-MTX, the voltage or agitation could have been adjusted upwards. This 




The metabolite DAMPA was also extracted by the same parameters as in Table 38. Its 
chemical structure suggested that it was less polar than MTX due to the loss of the glutamic 
acid part, which could possibly favor its partition into the non-polar SLM. The metabolite still 
contained a carboxylic acid, which was expected to interact with aliquat 336 the same way as 
MTX and 7-OH-MTX.  
 
Table 43. Experiment 17. Result from extraction of 5 µg/ml DAMPA. 









Peppermint oil + 
1% aliquat 336 
10 20 750 32.4 ± 1.0 
1Experiment is based on two parallels, where the deviation represents the difference between the mean value and 
the highest/lowest value. 
 
The extraction current in experiment 17 was stable, with a total of 100 µA for 2 samples. 
However, the extraction recovery in the acceptor solution in this experiment was lower than 
for MTX and 7-OH-MTX. An explanation could be that the single carboxylic acid was 
neutralized through the interaction with aliquat 336. The analyte was therefore no longer 
influenced by the electrical field, and due to its reduced polarity, it was not sufficiently 
released to the aqueous acceptor solution.  
 
  4.5.5 Thoughts on peppermint oil as an SLM in EME  
 
Peppermint oil is not a defined product. It consists of many different compounds, and it is 
uncertain what compounds are responsible for the observed effects. When extracting MTX 
through peppermint oil, some small peaks appeared in the chromatogram in addition to the 
MTX peak at 2.9 (Figure 44). These most likely represent different compounds from the 




Figure 44. Chromatogram of an acceptor solution showing the retention of MTX and 
unknown compounds leaked from peppermint oil. 
 
The two main components of peppermint oil are menthol and menthone, which accounts for 
40.7% and 23.4% of the oil, respectively (66). The structures of the two compounds are 
shown beneath.  
 
Figure 45. The two main components of peppermint oil (downloaded and modified from (67) 
and (68)). 
 
The only difference between the two structures is that menthol has an alcohol functional 
group, whereas menthone contains a ketone. Menthol is, like 1-octanol, an aliphatic alcohol, 




In order to obtain the best recoveries in EME with peppermint oil, multiple parameters would 
have to be optimized. This includes composition of the SLM (peppermint oil/aliquat 336 
ratio), volume and pH of acceptor/donor solution, volume of the SLM, time, agitation, and 
voltage. The best way to do this would be a factorial design of experiments. Due to limited 
time, and the problems discussed in section 4.7, it was decided not to go ahead with this. 
Instead, experiments with menthol and menthone were performed to find if it was possible to 
develop a method of MTX extraction using well-defined SLM ingredients.    
 
  4.6 Extraction of MTX through menthol and menthone with 
aliquat 336 as ionic carrier 
 
Since menthol and menthone are the two most prominent compounds of peppermint oil, the 
substances were obtained and used as SLM. The aim was to find the combination of the two 
compounds that would yield the same recoveries as obtained with peppermint oil. That way, 
the identity of the compounds responsible for the high recoveries could be determined. 
 
The water solubility of menthol and menthone was 0.69 g/L and 0.42 g/L, respectively (55, 
69), making them both good candidates as SLM in terms of low leakage into the aqueous 
solutions during extraction. A water solubility higher than 1 g/L is generally not 
recommended in EME (33). Menthone was obtained in oil form. It was easy to handle during 
EME, and therefore attempted as an SLM first. Menthol was obtained in solid form and had to 
be dissolved in another oil and/or heated prior to EME. 
 
8 samples were extracted through menthone at 10 V, 750 RPM, and 1% aliquat 336. The 
purpose was to observe at what time the recoveries were highest, at the given voltage. New 
vials were applied to the experiment to exclude the fact that a potentially high RSD was due 
to poor vial performance.  
 
Table 44. Constant parameters for experiment 18 and 19. 
Parameter Description 
Donor solution 40 mM phosphate buffer, pH 7.4 


















Figure 46. Extraction current for experiment 18. Each segment indicates removal of one 
sample from the EME instrument.  
 
The results from experiment 18 were difficult to interpret, as the recovery vs. time did not 
show linearity. The reason was most likely the high current and electrolysis during extraction, 
facilitating an unstable and unpredictable system. Figure 46 shows that the extraction current 
Sample Extraction time (min) Recovery acceptor solution (%) 
1 8 29.4  
2 10 22.2  
3 12  25.5  
4 14  37.9  
5 16  57.0  
6 18 16.1  
7 20 27.9  
8 22 52.1  
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was nearly 1000 µA distributed to 8 samples for the first 8 minutes. This means a current of 
approximately 125 µA running through each sample. However, unlike Figure 43, where two 
of the graphs show an increasing current with time, the trace in Figure 46 descends despite the 
high total current. This is usually a good sign in EME, as transport slows down and stabilizes.  
 
In conclusion, 10 V was most likely too high for the system in experiment 18. An experiment 
was therefore carried out at 8 V for 12 minutes.  
 
Table 46. Experiment 19. Result from extraction of 5 µg/ml MTX through menthone at 8 V. 









Menthone + 1% 
aliquat 336 
8 12 750 52.3 % ± 3.6 
 
The result supports the theory that the voltage in experiment 18 was too high. Compared to 
experiment 18, where 25.5% recovery was achieved after 12 minutes, 53.3% recovery was 
achieved after 12 minutes in experiment 19. The extraction current was stable and descending, 
with approximately 80 µA running through each sample. Figure 24 was used as an example 
current curve in section 3.5, and represents this experiment. More experiments could have 
been attempted, such as longer extractions at 8, 7, 6 and 5 V to yield higher recoveries.  
 
However, instead of optimizing parameters for extraction through menthone, menthol was 
added to the SLM. This compound is an aliphatic alcohol, and was theorized to be the 
component mainly responsible for the high recoveries obtained with peppermint oil. Since the 
compound existed in a solid form, it was mixed with menthone and heated for 5 minutes. This 
generated a more viscous liquid, which was thought to be favorable in terms of lowering the 
extraction current.  
 
A 75 % (w/v) menthol in menthone mixture was prepared, and 1% aliquat 336 was added. 




Table 47. Experiment 20. Result from extraction of 5 µg/ml MTX through menthol/menthone 
(3:1) 













menthone (3:1) + 
1% aliquat 336. 
10 15 750  29.9 ± 0.8 -2.0 ± 0.2 
1All experiments are based on two parallels, where the deviation represents the difference between the mean 
value and the highest/lowest value. 
 
Apparently, the inclusion of 75% menthol did not result in improvements in extraction 
recovery in this experiment. The pH reduction was not extensive, but higher recoveries were 
yielded with menthone alone, as shown in experiment 18. The proportion of menthol was 
therefore reduced, and the following experiment applied 50% (w/v) menthol in menthol.  
 
Table 48. Experiment 21. Result from extraction of 5 µg/ml MTX through menthol/menthone 
(1:1) 
SLM  Voltage 
(V) 





(1:1) + 1% aliquat 
336. 
10 10 750  36.7 ± 7.5 
1Experiment is based on two parallels, where the deviation represents the difference between the mean value and 
the highest/lowest value. 
 
Here, the extraction time was only 10 minutes, but recovery in the acceptor solution was still 
higher than in experiment 20. This suggests that the amount of menthol must not be too high 
compared to menthone. Experiment 21 yielded higher recoveries after 10 minutes compared 
to experiment 18. This suggested that the addition of menthol might be beneficial, but the 
ratio between menthol and menthone must be optimized further to yield recoveries close to 
the ones obtained with peppermint oil. For example, a menthol/menthone (2:1) ratio could 
have been experimented with at higher voltage and/or longer extraction time, as this ratio 




However, further experimentation with the two components were put on hold as an 
unexpected problem appeared, which will be discussed in the next sections.  
 
  4.7 Impairment of EME of MTX due to interference between 
anionic electrolytes and the SLM carrier   
 
  4.7.1 Discovery of problems related to NaCl in the donor solution 
 
Until now, a 40 mM phosphate buffer with no additional electrolytes had been used as the 
donor solution for EME of anionic MTX. However, during the experiments with menthone 
and menthol, phosphate buffered saline (PBS) with pH 7.4 was prepared as the donor 
solution. The PBS contained 0,01 M phosphate buffer, 0.137 M NaCl and 0.0027 M KCl. 
Upon the application of this donor solution, the extraction recoveries unexpectedly became 
0% (Table 49). In experiment 22, the samples were extracted for 15 minutes with an agitation 
of 750 RPM. As usual, the acceptor solution consisted of 10 mM NaOH.  
 
Table 49. Results from extraction of 5 µg/ml MTX from a PBS donor solution. 







menthone (3:1) +  
2% aliquat 336. 
10 99.7 ± 0.8 0.0 ± 0.0 
22B Menthol/ 
menthone (3:1) +  
2% aliquat 336. 
20 99.8 ± 0.3 0.0 ± 0.0 
1Experiments are based on two parallels, where the deviation represents the difference between the mean value 
and the highest/lowest value. 
 
Experiment 22A and B shows that 0% MTX was detected in the acceptor solution, and 100% 
was left in the donor solution (Table 49). This was unexpected, as it was reasonable to expect 
some degree of recovery based on the application of similar parameters in experiment 20. 
Nevertheless, there were two possible explanations for the absent recoveries: poor extraction 
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parameters in experiment 22, or the introduction of PBS as donor solvent.  
 
A new sample was extracted using parameters known to achieve reliable recoveries in the 
acceptor solution. 5 µg/ml MTX was extracted through peppermint oil with 1% aliquat 336 
according to the method that yielded 67.7% recovery after 16 minutes in experiment 13. The 
only difference from experiment 13 was the application of a PBS donor solution instead of 40 
mM phosphate buffer.  
 
Table 50 - Experiment 23. Result from extraction of 5 µg/ml MTX from a PBS donor 
solution through peppermint oil. 










Peppermint oil +  
1% aliquat 336. 
10 15 750 99.3 0.0  
 
 
Figure 47. Extraction current for experiment 23. The trace is from one EME extraction of one 
sample. 
 





















extraction current in Figure 47 shows a highly untypical pattern. The current was generally 
lower than expected, and behaved remarkably unstable.  
 
The first theory on why the recoveries dropped to 0% when using PBS, was that the newly 
introduced chloride ions from PBS were pulled by the electrical field in the direction of the 
anode and had a strong affinity to the positively charged carrier, aliquat 336. Due to the high 
concentration of chloride ions, aliquat 336 would be saturated and lose the ability to interact 
with, and transport MTX across the SLM. This may explain the lower extraction current in 
Figure 47.  
 
To investigate whether NaCl in PBS was responsible for the absent recoveries or not, an 
increasing amount of NaCl was added to a regular 40 mM phosphate buffer. The 
concentration of added NaCl ranged from 0.0025 M to 0.14 M. The samples were extracted 
through peppermint oil + 1% aliquat 336, at 10 V in 15 minutes, since this method had proved 
to yield reliable recoveries (Figure 40).  
 
Table 51. Experiment 24. Results from extraction of 5 µg/ml MTX from a donor solution 
with an increasing concentration of NaCl.  
Amount of NaCl in a 40 mM 
potassium phosphate buffer  
Recovery (%) 
0.0000 M 52.1% 
0.0025 M  11.5% 
0.0050 M 7.1% 
0.0075 M 8.8% 
0.0100 M  5.7% 
0.0200 M 1.6% 
0.0400 M 0.0% 
0.0700 M 0.0% 
 
The results in Table 51 clearly show a correlation between increasing concentration of NaCl 
in the donor solution and decreasing recovery of MTX in the acceptor solution. Already with 
0.04 M NaCl in the donor solution, no MTX was detected in the acceptor solution. This 
indicates that the extraction of MTX from plasma using aliquat 336 as carrier could be 
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problematic, since the physiologic concentration of Cl- is 0.098-0.106 M (70). Based on the 
experiments so far, it was confirmed that either Na+ or Cl- impaired the extraction of MTX 
from PBS across an SLM containing aliquat 336.  
 
  4.7.2 Extraction from a sodium phosphate buffer  
 
The next step was to confirm or disprove whether sodium ions were the source of the 
problem. Since MTX has two negative charges at physiologic pH (7.4), it was suggested that 
the analyte would become neutralized by the introduced Na+ ions (2COO-Na+) in the donor 
solution. Hence, MTX would no longer be influenced by the electrical field.  
 
A 40 mM sodium phosphate buffer with a pH of 7.4 was prepared (Table 4) and applied as the 
donor solution in experiment 25.  
 
Table 52. Experiment 25. Result from extraction of 5 µg/ml MTX from a sodium phosphate 
donor solution into a 10 mM NaOH acceptor solution. 




Peppermint oil + 
1% aliquat 336. 
10 20 750  66.2 ± 2.7 
1Experiment is based on two parallels, where the deviation represents the difference between the mean value and 
the highest/lowest value. 
 
The sodium phosphate buffer did not have an evident impact on the electrokinetic transfer of 
MTX across the SLM with aliquat 336 as a carrier. Based on Figure 13, MTX has a predicted 
solubility of 450 mg/ml at pH 7.4. Based on this, it seemed unlikely that the analyte interacted 
with sodium ions to such a degree that it would lose its negative charges in the donor solution. 
Furthermore, if the sodium ions were the source of the problem, one would assume that the 
same problem would apply to the potassium phosphate buffer. This buffer also contains 
monovalent cations (K+) with similar chemical properties as Na+. In conclusion, the 
possibility that sodium ions impaired EME of MTX was considered unlikely, and the focus 




  4.7.3 Different approaches to overcome the impact of Cl- ions in the 
donor solution 
 
Different experiments were carried out to determine if it was possible to raise the recoveries 
from 0%. For example, longer extractions were performed, examining whether this would 
eventually lead to a dissociation of the interactions between aliquat 336 and Cl- ions, allowing 
more transport of MTX. Also, the concentration of aliquat 336 was increased from 1% to 2% 
in the SLM, to investigate whether this would increase the capacity of analyte transport. In 
experiment 26C, 1-octanol was applied as SLM instead of peppermint oil, in case that the 
reason for absent recoveries was due to an interaction between Cl- ions and peppermint oil.  
 
In experiment 26, PBS was applied as donor solution, and 10 mM NaOH as acceptor solution. 
The agitation was 750 RPM.  
 
Table 53. Results from extraction of 5 µg/ml MTX in order to study the impact of Cl- ions 
from a PBS donor solution.  










26A Peppermint oil + 
1% aliquat 336 
20 30 98.6 2.0 
 
26B Peppermint oil + 
2% aliquat 336 
15 20 99.7 0.0 
 
26C 1-octanol + 1% 
aliquat 336 
5 15 96.9 0.0 
 
No MTX was detected in the acceptor solution in experiment 26B and 26C. The reason why 
2% was achieved in experiment 26A might have been due to passive transport of MTX across 
peppermint oil without any interaction with the carrier. Experiment 9A supports this theory, 
as 6.9% MTX was detected in the acceptor solution after extraction at 100 V in 15 minutes 
without an ionic carrier in the peppermint oil.  
 
In experiment 26B, 2% aliquat 336 in the SLM was most likely not a sufficiently high 
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concentration to allow ionic transport of MTX, as the carrier was occupied by Cl-. Also, the 
voltage and time might have been insufficient to allow passive transport of MTX independent 
of aliquat 336.   
 
In both experiment 26A and 26B, the extraction current was approximately 80 µA. Based on 
this observation, the time or voltage was not adjusted further upwards in experiment 26A, and 
the amount of carrier was not set higher than 2% in experiment 26B. These adjustments 
would lead to higher current in the system. Based on previous experience, extraction 
recoveries normally decreased as a result of high current, electrolysis and consequent pH 
changes.  
 
Experiment 26C confirmed that recovery was 0% regardless of whether 1-octanol or 
peppermint oil was applied as the SLM, which strengthened the theory that the problem 
regarded the interaction between chloride ions and aliquat 336.  
 
New experiments were performed by increasing the concentration of chloride ions in the 
acceptor solution. In theory, the flux of ions across the SLM is partly dependent on ion 
balance (χ), which is the ratio between the total concentration of ions in the donor and 
acceptor solutions. A low χ value favors extraction kinetics (71). Therefore, it was suggested 
that a higher concentration of NaCl in the acceptor solution would prevent the Cl- ions in the 
donor solution from diffusing into the SLM and favor the extraction of MTX.  
 
0.5 M NaCl was added to the acceptor solution, which previously only consisted of 10 mM 
NaOH. The agitation was set to 800 RPM this time, with hopes that it could more easily break 





















27A 10 mM NaOH 
+ 0.5 M NaCl 
Peppermint oil + 
1% aliquat 336  
20  15 2.7 
27B 10 mM NaOH 
+ 0.5 M NaCl 
Peppermint oil + 
1% aliquat 336 
10  15 1.1 
1Experiment 27A and 27B are based on three parallels, with an RSD of 98.7 and 70.7%, respectively. 
 
The high concentration of NaCl in the acceptor solution might have had a slight positive 
impact on the extraction recoveries in experiment 27. However, the aliquat 336 carrier was 
presumably still saturated with chloride ions and incapable of sufficient interaction with 
MTX.  
 
The extraction of MTX from PBS without the application of voltage was attempted, to see if 
passive diffusion of MTX was possible despite the chloride ions in the donor solution. Three 
experiments were performed, with parameters altering between acceptor solution 
composition, amount of aliquat 336 in the SLM, and extracting time.  
 
Table 55. Results from extraction of 5 µg/ml MTX from PBS without applying voltage.  
Experiment Acceptor 
solution 







28A 10 mM NaOH Peppermint oil + 
1% aliquat 336 
30 800 2.2 
28B 10 mM NaOH Peppermint oil + 
10% aliquat 336 
45 800 0.0 ± 0.0 
28C 10 mM NaOH 
+ 0.5 M NaCl 
Peppermint oil + 
10% aliquat 336 
45 800 1.4 ± 0.4 
1Experiment 28B and 28C are based on two parallels, where the deviation represents the difference between the 




The results in experiment 28 were difficult to interpret, as the recoveries were generally very 
poor. It is uncertain why experiment 28A yielded higher recovery than in 28B and 28C. It 
might be due to random variance, and it is unlikely that the result would be statistically 
significant if experiment 28 was performed multiple times. Nevertheless, it seemed like the 
chloride ions had a great affinity to the carrier, regardless of influence from the electrical 
field.  
 
  4.7.4 Impact of plasma anions on aliquat 336, other than chloride 
 
Since it became increasingly clear that the interaction between Cl- ions and aliquat 336 was 
responsible for the poor recoveries of MTX, the extraction of the analyte from plasma through 
an SLM containing aliquat 336 seemed unpromising. This was unfortunate, since the carrier 
had been the key component responsible for high extraction recoveries.  
 
The idea of precipitation of chloride ions came up early in the phase of problem solving. 
However, before doing this, experiments were performed to assure that other anions in the 
plasma did not affect extraction recoveries like Cl- did. Electrolytes present in the plasma are 
sodium, chloride, magnesium, potassium, bicarbonate, phosphorous and calcium (56).  
Hence, bicarbonate (HCO3
-) was the only anionic compound, in addition to chloride, that 
could be problematical to EME.  
 
A donor solution containing Milli-Q water and NaHCO3 in a concentration that mimicked the 
concentration of bicarbonate in blood was prepared (Table 4), and spiked with 5 µg/ml MTX. 
The sample was extracted by parameters listed in Table 56. Additionally, 5 µg/ml MTX was 
extracted from pure Milli-Q-water to compare the result with the NaHCO3 experiment. The 
reason why Milli-Q water was chosen as a solvent instead of 40 mM phosphate buffer was to 









Table 56. Constant parameters for experiment 29 and 30.  
Parameter Description 
SLM Peppermint oil + 1% aliquat 336 
Acceptor solution 10 mM NaOH, pH 12 
Time 15 minutes 
Voltage 5 V 
Agitation 750 RPM 
 
Table 57. Results from extraction of 5 µg/ml MTX from a NaHCO3 containing donor 
solution, and a Milli-Q water containing donor solution.  
Experiment Donor solution Recovery acceptor 
solution (%)1 
29A 0.025 M NaHCO3 in  
Milli-Q water 
22.2 ± 1.8 
29B Milli-Q water 23.3 ± 3.7 
1Experiments are based on two parallels, where the deviation represents the difference between the mean value 
and the highest/lowest value. 
 
NaHCO3 presumably did not have a negative influence on the carrier aliquat 336, since 
experiment 29A yielded almost the same recovery as experiment 29B. Theories regarding 
why the HCO3
- anion did not have a negative impact on the carrier will be discussed in 
section 4.7.6. Nevertheless, the possibility of negative interference from plasma bicarbonate 
ions in EME was excluded.  
 
  4.7.5  Precipitation of Cl- ions 
 
Since Cl- was identified as the main problem in EME of MTX using aliquat 336 as carrier, an 
attempt to remove Cl- from the solution was made. Silver nitrate was obtained for the 
precipitation of Cl- ions based on the following reaction: 
 




However, by precipitating chloride, negatively charged nitrate ions would remain in the donor 
solution. Considering this, another experiment was carried out to see the impact of nitrate ions 
on aliquat 336. Based on the stoichiometry of equation 8, the concentration of AgNO3 needed 
to precipitate the physiological concentration of NaCl in plasma (0.154 M) would be 0.154 M. 
Also, the amount of remaining nitrate ions after precipitation of 0.154 M NaCl would be 
0.154 M, because of the molar ratio of 1:1. 
 
A donor solution containing Milli-Q water and 0.154 M KNO3 was prepared and spiked with 
5 µg/ml MTX. The sample was extracted by the parameters listed in Table 56.  
 
Table 58. Experiment 30. Result from extraction of 5 µg/ml MTX from a KNO3 containing 
donor solution. 
Donor solution Recovery acceptor 
solution (%)1 
0.154 M KNO3 in 
Milli-Q water 
3.4% ± 0.2 
1Experiment is based on two parallels, where the deviation represents the difference between the mean value and 
the highest/lowest value. 
 
The reduced recovery in experiment 30 compared to experiment 29 suggests that the nitrate 
ions act similarly as chloride ions, in terms of blocking transport of MTX across the SLM.  
This could therefore pose a problem with the precipitation of Cl- with AgNO3.  
 
Nevertheless, an experiment of precipitation was attempted. Since a PBS solution contained 
0.137 M NaCl and 0.0027 M KCl, a concentration of 0.140 M AgNO3 was used to ensure 
precipitation of all chloride ions from the PBS solution. However, to avoid excessive dilution 
of the sample, the AgNO3 solution was prepared with twice as high concentration, 0.28 M. 
That way, 1 ml 7.5 µg/ml MTX in PBS was mixed with 0.5 ml 0.28 M AgNO3. The tube was 
vortexed for one minute, prior to centrifugation for five minutes on an Allegra™ X-22R 
Centrifuge (Beckman Coulter (Brea, CA, USA)), with a relative centrifugal force (RCF) of 
2800 for five minutes.  
 
Before EME, 200 µl of the supernatant was analyzed on HPLC to observe whether MTX had 
recovered the precipitation and centrifugation process. The theoretical amount of MTX in the 
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supernatant was 5 µg/ml. However, the remaining amount of MTX was only 4.0% when 
comparing the supernatant with a standard solution of 5 µg/ml MTX in PBS, suggesting that 
most of the MTX had coprecipitated/sedimented with the AgCl.  
 
To confirm or disprove whether it was the centrifugation process itself that removed MTX 
from the solution or not, 5 µg/ml MTX in PBS was centrifuged without addition of 
precipitant. This time, the recovery was 100% after centrifugation. This suggested that MTX 
might have precipitated from the addition of AgNO3. Even though MTX has a high solubility 
in PBS at pH 7.4, the combination of high concentration of Ag+ and centrifugation might have 
led to the formation of an insoluble complex between MTX and Ag+ (-COO-Ag+).  
 
Since MTX most likely co-precipitated with AgCl, the supernatant was spiked with new 5 
µg/ml MTX after precipitation. This sample was extracted to check if the extraction recovery 
was similar to the one obtained when extracting MTX from a nitrate containing donor 
solution in experiment 30, which was 3.4% (Table 58).  
 
Table 59. Experiment 31. Result from extraction of 5 µg/ml MTX from supernatant after 
precipitation of AgCl.  







Peppermint oil + 
1% aliquat 336 
10 20  750 1.1 ± 0.1 
1Experiment is based on two parallels, where the deviation represents the difference between the mean value and 
the highest/lowest value.  
 
Based on the precipitate, much of the chloride ions had reacted with silver nitrate. However, 
the presence of nitrate ions and possibly chloride ions in the donor solution prevented high 
extraction recovery.  
 
In conclusion, AgNO3 was not a good choice for the precipitation of chloride ions in PBS. 
There were two reasons for this. The first reason was that only a small amount of MTX was 
present in the supernatant after precipitation and centrifugation. Secondly, nitrate ions 
remained in the sample after precipitation of Cl-, which also appeared to interact with aliquat 
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336 and hinder MTX extraction. A way to combat these problems could be to use another Ag-
salt for precipitation, such as Ag2SO4. This compound would generate SO4
-2 ions in the donor 
solution after precipitation, which could be favorable for EME, as discussed in section 4.7.6. 
However, Ag2SO4 has very low solubility in water (1.4 x 10
-5 M at 25 °C) (72). Also, for 
EME of MTX to be a routine technique in the future, it is undesirable with a time-consuming 
process including several operational steps.  
 
  4.7.6 Monovalent vs. divalent anion effect on aliquat 336 
 
At this point, it was established that chloride and nitrate ions strongly impaired EME of MTX. 
Both anions had the common property of being small and carrying one negative charge. To 
investigate whether other monovalent anions acted in a similar fashion, 0.14 M sodium iodide 
was added to a donor solution containing Milli-Q water.  
 












Peppermint oil + 
1% aliquat 336 
0.14 M NaI 
in Milli-Q 
water 
5 15 750 0.1 
 
Experiment 32, 30, and the experiments with chloride containing donor solutions supports the 
theory that monovalent anions interact with aliquat 336 and prevents MTX from entering the 
SLM.  
 
However, the monovalent theory did not seem to apply for NaHCO3 in experiment 29. The 
pKa value for bicarbonate ↔ carbonic acid is 6.4. The pKa value for bicarbonate ↔ carbonate 
is 10.3 (73). This means that NaHCO3 mostly exist in monovalent state from pH 6.4-10.3.   
 
One explanation to why the bicarbonate ions did not affect the function of aliquat 336, can be 
that it was added at a lower concentration; 0.025 M NaHCO3 was added to Milli-Q water, 
compared to 0.154 M KNO3. Also, bicarbonate might to some degree have equilibrated 
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between bicarbonate and carbonate in the donor solution. The donor solution in experiment 
29A had a pH of 8.48, and the pH was presumably higher in the donor solution/SLM interface 
due to the electrical double layer. Since some of the molecules might have existed in divalent 
state and kept a net negative charge in the SLM, they could be pulled towards the positively 
charged anode by the electrical field. In experiment 29, the pH drop in the acceptor solution 
was only 1 unit, and was therefore 11 at the end of extraction, in which the divalent carbonate 
ions are the dominant species. Extraction of the divalent carbonate ions into the acceptor 
solution might therefore have made room for MTX to interact with aliquat 336.  
 
Divalent ions in the donor solution have seemed unproblematic for EME. For example, in 
most experiments, a 40 mM phosphate buffer was used. Phosphoric acid has three 
dissociation constants, with pKa 2.16, 7.21 and 12.32 (74). At pH 7.4, the dominating form is 
HPO4
2-, accounting for 74% of the molecules. (Figure 48). The divalent anions might have 
been extracted across the SLM due to the net negative charge. Alternatively, the buffer ions 
were too bulky in structure to interact strongly with aliquat 336. Also, they existed in 
relatively low concentration (0.04 M) which might have prevented excessive saturation of 
aliquat 336.  
 
Figure 48. Predicted distribution of Phosphoric acid (%) with different charge at pH 0-14. 




MTX is also a divalent anion, which supports the theory on why it was released from the 
carrier aliquat 336. The net negative charge of the molecule within the SLM might have 
contributed to its pull against the anode in the acceptor solution. However, more factors could 
have been responsible for the high recoveries of MTX. For example, its high polarity was 
responsible for low affinity to the SLM. Also, its relatively large molecular size might have 
prevented the analyte from strongly interacting with aliquat 336.  
 
In experiment 17, DAMPA was extracted through an SLM containing aliquat 336. The 
recovery in this experiment was lower than for the same experiment applying the analytes 
MTX and 7-OH-MTX. The fact that DAMPA is monovalent, and MTX and 7-OH-MTX are 
divalent ions might explain the poor recovery of DAMPA.   
 
In conclusion, it was established that the small and monovalent anions chloride, nitrate, and 
iodide strongly impaired the extraction of MTX, most likely due to strong interactions 
between the anions and the positively charged carrier aliquat 336. To further investigate the 
function of aliquat 336, more anions (monovalent and divalent) would have to be tested 
systematically in order to understand the relationship between number of positive or negative 
charges and extraction efficiency.  
 
  4.7.7 Experiments with a new ionic carrier bis-(2 ethylhexyl)amine 
(BEA) 
 
Based on the experiments so far, the extraction of MTX from a donor solution with a 
physiological concentration of NaCl through an SLM containing aliquat 336 was not possible. 
Also, the nitrate ions left in solution after precipitation of chloride ions would equally impair 
the extraction. Thus, a new carrier was needed to extract MTX from plasma. A cationic 
carrier, bis-(2 ethylhexyl)amine (BEA), was obtained from Department of Pharmacology, 
University of Oslo. The compound has structural similarities to DEHP (Figure 9), except that 




Figure 49. Chemical structure of bis-(2 ethylhexyl)amine (BEA). Downloaded from (57). 
 
Unlike aliquat 336, this carrier does not keep a permanent positive charge. Its predicted pKa 
value is 11.1, meaning that below this pH, an increasing fraction of the molecule exists with a 
+1 charge at the nitrogen atom (76). Above pH 11.1, an increasing fraction of the molecule 
would be neutral.  
 
Before using the new carrier in extraction of MTX from PBS, a regular 40 mM phosphate 
buffer was chosen as the donor solution. The intention was to see if the carrier functioned as 
well as aliquat 336 under conditions without chloride, which could pose a problem to 
extraction. 
 
10 mM NaOH was chosen as the acceptor solution. The voltage was set to 100 V, based on a 
test extraction from a blank donor solution to see how much current the new carrier generated. 
The extraction current was approximately 10 µA with 1% BEA, and slightly higher (15-20 
µA) with 10% BEA in the SLM.  
 
Table 61. Results from extraction of 5 µg/ml MTX through peppermint oil + BEA from a 40 
mM phosphate buffer. 
Experiment SLM Voltage 
(V) 




33A Peppermint oil 
+ 1% BEA 
100 15 750 0.7 ± 0.7 
33B Peppermint oil 
+ 10% BEA 
100 15 750 0.0 ± 0.0 
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1Experiments are based on two parallels, where the deviation represents the difference between the mean value 
and the highest/lowest value. 
 
The extraction recoveries in the acceptor solutions were practically absent. The cause of this 
is unclear, but the low extraction current indicated a poor flux of ions across the SLM, despite 
the application of 100 V. In experiment 33, the donor solution still contained all MTX after 
the extraction.   
 
The BEA carrier was added to 1-octanol instead of peppermint oil, since 1-octanol is more 
frequently applied as SLM in EME. Based on a test extraction from a blank donor sample, the 
voltage was set to 50 V, generating approximately 40 µA.  
 













50 15 750 33.2  23.7  
 
Compared to experiment 33, where the extraction current was approximately 10 µA, the 
extraction current in experiment 34 was initially 40 µA, increasing to 160 µA at the end of 
extraction. This also explained why the recovery was significantly higher in experiment 34 
than experiment 33. The cause of the improved function of the carrier with 1-octanol 
compared to peppermint oil remains unknown.  
 
It was hypothesized that BEA could function even better if added to the donor solution, in 
addition to being present in the SLM. That way, more carrier molecules would be able to 
interact with MTX in donor solution, form ion complexes and more easily partition into the 
SLM. According to Chemicalize, BEA has a solubility of 3,4 mg/ml at pH 7.4 (76). A donor 








Table 63. Experiment 35. Result from extraction of 5 µg/ml MTX from a donor solution 
containing BEA.  















phosphate buffer  
+ 3.4 mg/ml BEA 
1-Octanol 
+ 1% BEA 
50 15 750 11.4 % 30.9 
 
The addition of carrier to the donor solution enhanced the recovery in experiment 35. Also, 
more of the MTX molecules had presumably been transported from the donor solution and 
into the SLM. However, the current gradually increased during the extraction, from 20 to 400 
uA by 10 minutes. The current stabilized at 400 uA for the remaining 5 minutes, but this was 
still much higher than recommended in EME. For additional experiments, the voltage could 
be reduced, but the purpose with experiment 34 and 35 was to see if BEA could function as an 
ionic carrier to MTX.  
 
Since BEA appeared to be promising for the extraction of MTX from a 40 mM phosphate 
buffer, the carrier was tested in extraction from PBS. Experiment 34 and 35 were performed 
again, but with PBS as donor solution, in hopes that chloride ions would not interact as 
strongly with BEA as with aliquat 336. Like earlier, the voltage was 50 V, the extraction time 
was 15 minutes, the agitation was 750 RPM, and the SLM was composed of 1-octanol + 1% 
BEA.  
 
Table 64. Results from extraction of 5 µg/ml MTX from PBS using the ionic carrier BEA. 




36A PBS  
 
99.4  0 
36B PBS +  





In experiment 36A and 36B, almost all MTX was found in the donor solution after EME. The 
application of PBS lowered the recoveries from 23.7% and 30.9% to 0% and 1.1%. The 
current in experiment 36 was high (200 µA for 36A and up to 400 µA for 36B) However, it 
was buffer ions that accounted for the high current. All the added MTX was left in the donor 
solution and had apparently no interaction with the SLM.  
 
In conclusion, it was likely that the new cationic carrier BEA got saturated with chloride ions 
the same way as aliquat 336. Hence, there was no good solution to the problem related to 
chloride ions in the donor solution in combination with cationic carrier.  
 
  4.8 Extraction of MTX from plasma  
 
Due to all the problems with the extraction of anionic MTX from a chloride containing donor 
solution, attempts were made to extract MTX as a cation. The high concentration of NaCl in 
plasma would most likely make extraction of anionic MTX through aliquat 336 impossible. 
EME of spiked plasma was therefore performed using the method that yielded 7.1% in section 
4.2.  
 
Approximately 4 ml blood was obtained in EDTA tubes and centrifuged on a Universal 
Refrigerated Centrifuge Model 5930 (Kubota, Japan) with a relative centrifugal force (RCF) 
of 2100 in 10 minutes. The plasma was spiked with 10 µM MTX. After dilution with 
phosphate buffer and pH adjustment to 2.6 with HCl, the final concentration of MTX in the 
donor solution was 4.39 µM. Tree identical samples were extracted simultaneously, by the 
extraction conditions in Table 65. The acceptor solutions were analyzed on LC-MS/MS after 
EME.  
 
For preparation of the external standard solution, a blank plasma sample was preprocessed the 
same way as the spiked sample (diluted with phosphate buffer and pH adjusted to 2.6) and 
extracted by same procedure. After EME, the acceptor solution was spiked with 4.39 µM 
MTX and analyzed by LC-MS/MS. See Table 4 for detailed information concerning the 




Table 65. Extraction conditions for experiment 37.  
Parameter  Value 
Donor solution Plasma spiked with 4.39 µM MTX 
Acceptor solution 50 mM HCl pH 1.3 
SLM NPPE + 20% DEHP 
Voltage  50 V 
Time 15 minutes 
Agitation  750 RPM 
 
Table 66. Experiment 37. Results from extraction of 4.39 µM MTX from plasma.   
Sample Analyte peak area1 Recovery (%) 
1 44 700 ± 4 700 5.8  
2 47 200 ± 2 600 6.2  
3 34 700 ± 300 4.5 
External standard 766 500 ± 4 500 
1All results are based two injections from the same sample, where the deviation represents the difference 




Figure 50. LC-MS/MS chromatograms showing the elution and intensity of sample 1 (A), 2 
(B) and 3 (C) from experiment 37. From all the samples, including the standard (D), 1 µl was 




Figure 51. Extraction current for experiment 37. The trace is from one EME extraction of 
three samples, representing the sum of the extraction currents of all samples. 
 
The recoveries in experiment 37 were poor, as expected based on the results in section 4.2. 
The mean recovery was 5.5% with an RSD of 13.1%. However, this was not far from the 
recovery achieved by extraction of MTX from phosphate buffer (7.1%), which is promising 
for future development of the method, although it is uncertain whether it is possible to extract 
protonated MTX with high levels of recovery. The extraction current was low and descending 
for the three samples (Figure 51), indicating a stable system with no adverse electrolysis. It 
thus appears that the different constituents in plasma did not interfere substantially with the 
extraction of MTX over an SLM consisting of NPPE and 20% DEHP. For future experiments, 
the voltage could have been adjusted upwards, which might have facilitated greater transport 
of MTX across the SLM.  
 
The difference between the highest and lowest analyte peak area was relatively high between 
injections from the same sample (Table 65). This was especially evident for sample 1 (Figure 
50A). Differences in signal between injections were reoccurring, and occurred in standard 
samples dissolved in methanol, as discussed in section 3.7.3. To compensate for this, a fixed 
concentration of an IS could be added to the sample. That way, the analyte and IS would be 



















between them could be measured for a better estimate of the concentration of MTX.  
 
The EME extract appeared clear and visibly free from contaminants, which is beneficial for 
injection into the LC-MS instrument. A high sample clean-up enhances the performance of 
the LC-MS instrument, since matrix effects and subsequent signal suppression of the analyte 
is avoided to a greater extent (16). Also, the need for maintenance will be reduced, as 
contamination is avoided to a greater extent.  
 
    
Figure 52. Donor and acceptor solution after EME of MTX from plasma.  
 
5  Limitations  
 
Based on all the experiments performed, several aspects made the extraction of MTX 
particularly challenging. The extraction of MTX as a cation resulted in poor recoveries. This 
might be explained by an elevated pH in the acceptor solution or the SLM/acceptor solution 
interface, with consequent reduction in the release of MTX from the ionic carrier DEHP.  
 
The conducive vials appeared to lose their performance over time. Most likely, this was due to 
substances accumulating in the vials over time, which altered their conductive properties. This 
resulted in varying extraction recoveries and high RSD values, confounding the process of 
EME method development. New and unused vials provided more reproducible results, and for 
EME to become a routine method, disposable vials must be developed to avoid variance in 
conductivity.   
 
The ionic carriers used to transport anionic MTX across the SLM (aliquat 336 and BEA) both 
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interacted with chloride, impairing the extraction of MTX from PBS. Even though the 
extraction of anionic MTX from plasma was not practically performed, the physiological 
concentration of chloride in plasma would in theory be excessive and hinder the function of 
the ionic carriers. The ideal carrier for MTX has obviously not yet been identified. 
 
Considering that a range of different parameters were tested (composition of SLM, 
donor/acceptor solutions, voltage, time, and agitation), a systematic approach was required to 
draw meaningful conclusions from the extraction results. This included a consistent change of 
one parameter at a time to observe the relationship between different extraction conditions 
and recovery in the acceptor solution. Unnecessary time was spent on changing multiple 
parameters at the same time, hoping it would facilitate high recoveries faster. The most 
efficient approach for EME would be to perform a fractional factorial design of experiments. 
This would give a clear indication on the relationship between extraction parameters and 
results, but without spending too much time, since multiple parameters are changed 




In the experiments conducted in this thesis, EME of the analytes MTX, 7-OH-MTX and 
DAMPA have been performed for the first time. A range of different SLMs were applied, 
including NPOE, NPPE, 1-octanol, 1-nonanol, peppermint oil, menthone, and a mixture of 
menthone and menthol. Also, ionic carriers, such as DEHP, aliquat 336 and BEA were added 
to the SLM to facilitate migration of the polar analyte. The combination of SLM and ionic 
carrier that yielded the highest recovery of MTX throughout the study was peppermint oil 
with 1% aliquat 336. By adjusting other extraction parameters like voltage, time, and 
agitation, a recovery of 77.3% MTX, 59.0% 7-OH-MTX and 32.4% DAMPA, was achieved 
in the acceptor solution. Since peppermint oil is not a defined product, the future focus should 
be directed towards its main components, menthol and menthone, by finding the combination 
that would facilitate the best extraction of MTX. 
 
At Rikshospitalet in Oslo, ≈ 70% recovery of MTX and its metabolites from samples of 
patients treated with glucarpidase is achieved by protein precipitation. In the present study, 
the recovery of MTX was higher, fulfilling a main aim of the study. However, the SLM used 
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to achieve this recovery (1% aliquat 336 in the SLM), was not applicable to EME of MTX 
from plasma samples. Anionic chloride ions strongly impaired the extraction of MTX by 
interacting with aliquat 336 and blocking transport of the analyte. Hence, the physiological 
concentration of Cl- in plasma would not allow EME of MTX by the method developed using 
buffer without monovalent anions in the donor vial. Therefore, EME of MTX from plasma 
was performed independent of aliquat 336, by extracting MTX as a protonated base. This 
experiment yielded a mean recovery of 5.5% (RSD = 13.2%) in the acceptor solution.  
 
Thus, no satisfactory EME method for the extraction of MTX and its metabolites from plasma 
was achieved in this study. The main challenge was not the acidity of the analytes. There are 
several studies on EME of acidic analytes, such as ibuprofen, diclofenac, and ketoprofen, 
where successful extraction from plasma was achieved (37, 77, 78). The challenge with MTX 
and its metabolites was their high polarity, resulting in a definite requirement for an ionic 
carrier in order to achieve transport across the SLM. Both aliquat 336 and BEA lost their 
ability to transport MTX in the presence of Cl-, and it thus appears as if another ionic carrier 
with less interference with Cl- must be found.  
 
In conclusion, the large body of results significantly contribute to a theoretical and practical 
understanding of conditions facilitating EME extraction of acidic and polar compounds like 
MTX and its metabolites. The multiple observations noted throughout the study, such as the 
importance of controlling the extraction current to avoid electrolysis, the composition of the 
SLM to facilitate partition of the analytes into the SLM, and the significance of an ionic 
carrier to transport the analytes across the SLM and into the acceptor solution, provide an 
improved general understanding of EME of acidic and polar compounds. While forming a 
base for establishment of an applicable method for MTX and its metabolites, the work also 
paves the way for methodological development of other TDM candidates with similar 
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